<!DOCTYPE html>
<html lang="hu">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Opicapone a Parkinson-kór kezelésében</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <style>
        body { font-family: 'Inter', sans-serif; }
        .text-shadow {
            text-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        .medical-accent {
            background: linear-gradient(90deg, #059669 0%, #10b981 100%);
        }
    </style>
</head>
<body class="m-0 p-0">
    <div class="w-full min-h-screen flex items-center justify-center" style="width: 1280px; min-height: 720px; background-color: #1e3a8a;">
        <div class="text-center text-white px-16 py-8">
            <div class="mb-8">
                <i class="fas fa-brain text-6xl text-green-300 mb-4"></i>
            </div>
            
            <h1 class="text-5xl font-bold mb-6 text-shadow leading-tight">
                Opicapone a Parkinson-kór<br>
                kezelésében
            </h1>
            
            <h2 class="text-2xl font-medium mb-8 text-blue-100">
                Tudományos útmutató neurológusok számára.<br>
		Készítette: Dr. Bálint Zsolt
            </h2>
            
            <div class="bg-white bg-opacity-10 backdrop-blur-sm rounded-xl p-6 mb-8 border border-white border-opacity-20">
                <div class="text-xl font-semibold mb-2">ONGENTYS® (opicapone)</div>
                <div class="text-lg text-blue-100">
                    Harmadik generációs COMT inhibitor<br>
                    Napi egyszeri adagolás
                </div>
            </div>
            
            <div class="flex items-center justify-center space-x-8 text-sm">
                <div class="flex items-center space-x-2">
                    <i class="fas fa-hospital text-green-300"></i>
                    <span>Evidence-based medicina</span>
                </div>
                <div class="flex items-center space-x-2">
                    <i class="fas fa-microscope text-green-300"></i>
                    <span>Klinikai gyakorlat</span>
                </div>
                <div class="flex items-center space-x-2">
                    <i class="fas fa-user-md text-green-300"></i>
                    <span>Neurológiai szakértelem</span>
                </div>
            </div>
            
            <div class="mt-12 medical-accent h-1 w-32 mx-auto rounded-full"></div>
        </div>
    </div>
</body>
</html>


<!DOCTYPE html>
<html lang="hu">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Bevezetés és Farmakokinetika</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        body { font-family: 'Inter', sans-serif; }
        .gradient-bg-slide2 { 
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
        }
        .medical-accent {
            background: linear-gradient(90deg, #059669 0%, #10b981 100%);
        }
        .blue-accent {
            background: linear-gradient(90deg, #1e3a8a 0%, #3b82f6 100%);
        }
        .mechanism-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
        }
        .pharma-box {
            background: linear-gradient(135deg, #f0fdf4 0%, #dcfce7 100%);
        }
    </style>
</head>
<body class="m-0 p-0">
    <div class="w-full gradient-bg-slide2" style="width: 1280px; min-height: 720px;">
        <div class="blue-accent h-16 flex items-center px-8">
            <div class="flex items-center space-x-4 text-white">
                <i class="fas fa-capsules text-2xl"></i>
                <h1 class="text-2xl font-bold">Bevezetés és Farmakokinetika</h1>
            </div>
        </div>

        <div class="px-8 py-6">
            <div class="grid grid-cols-2 gap-8 h-full">
                <div class="space-y-6">
                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-blue-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-info-circle text-blue-500 mr-3"></i>
                            Mi az opicapone?
                        </h2>
                        <div class="space-y-3 text-gray-700">
                            <div class="flex items-start space-x-3">
                                <i class="fas fa-check-circle text-green-500 mt-1"></i>
                                <span><strong>Harmadik generációs</strong> COMT inhibitor</span>
                            </div>
                            <div class="flex items-start space-x-3">
                                <i class="fas fa-check-circle text-green-500 mt-1"></i>
                                <span><strong>Egyszer naponta</strong> alkalmazható (50 mg)</span>
                            </div>
                            <div class="flex items-start space-x-3">
                                <i class="fas fa-check-circle text-green-500 mt-1"></i>
                                <span><strong>Perifériás hatás</strong> - nem jut át a vér-agy gáton</span>
                            </div>
                            <div class="flex items-start space-x-3">
                                <i class="fas fa-check-circle text-green-500 mt-1"></i>
                                <span><strong>Reverzibilis</strong> enzimgátlás</span>
                            </div>
                        </div>
                    </div>

                    <div class="mechanism-box rounded-xl shadow-lg p-6 border-l-4 border-blue-400">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-cogs text-blue-400 mr-3"></i>
                            COMT gátlás mechanizmusa
                        </h2>
                        <div class="space-y-4">
                            <div class="bg-white bg-opacity-70 rounded-lg p-4">
                                <div class="text-sm font-semibold text-gray-600 mb-2">Levodopa metabolizmus:</div>
                                <div class="text-xs text-gray-700">
                                    L-DOPA → <span class="text-red-600 font-bold">COMT</span> → 3-OMD<br>
                                    <span class="text-green-600">↓ Opicapone gátlás</span><br>
                                    L-DOPA → Dopamin (agy)
                                </div>
                            </div>
                            <div class="flex items-center justify-between text-sm">
                                <span class="bg-green-100 text-green-800 px-3 py-1 rounded-full">
                                    ↑ Bioelérhetőség
                                </span>
                                <span class="bg-blue-100 text-blue-800 px-3 py-1 rounded-full">
                                    ↑ Hatástartam
                                </span>
                            </div>
                        </div>
                    </div>

                    <div class="pharma-box rounded-xl shadow-lg p-6 border-l-4 border-green-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-star text-green-500 mr-3"></i>
                            Klinikai előnyök
                        </h2>
                        <div class="grid grid-cols-2 gap-4 text-sm">
                            <div class="space-y-2">
                                <div class="flex items-center space-x-2">
                                    <i class="fas fa-clock text-orange-500"></i>
                                    <span>Napi 1× adagolás</span>
                                </div>
                                <div class="flex items-center space-x-2">
                                    <i class="fas fa-shield-alt text-blue-500"></i>
                                    <span>Jó tolerálhatóság</span>
                                </div>
                            </div>
                            <div class="space-y-2">
                                <div class="flex items-center space-x-2">
                                    <i class="fas fa-heartbeat text-red-500"></i>
                                    <span>Nincs hepatotoxicitás</span>
                                </div>
                                <div class="flex items-center space-x-2">
                                    <i class="fas fa-eye text-purple-500"></i>
                                    <span>Nincs vizeletszín váltás</span>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-6">
                    <div class="bg-white rounded-xl shadow-lg p-6">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-chart-line text-purple-500 mr-3"></i>
                            Farmakokinetikai profil
                        </h2>
                        <div style="height: 280px;">
                            <canvas id="pharmaChart"></canvas>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-table text-indigo-500 mr-3"></i>
                            Farmakokinetikai paraméterek
                        </h2>
                        <div class="grid grid-cols-2 gap-4">
                            <div class="space-y-3">
                                <div class="bg-gray-50 rounded-lg p-3">
                                    <div class="text-sm font-semibold text-gray-600">Felezési idő</div>
                                    <div class="text-lg font-bold text-blue-600">1-3 óra</div>
                                </div>
                                <div class="bg-gray-50 rounded-lg p-3">
                                    <div class="text-sm font-semibold text-gray-600">Tmax</div>
                                    <div class="text-lg font-bold text-green-600">2-4 óra</div>
                                </div>
                            </div>
                            <div class="space-y-3">
                                <div class="bg-gray-50 rounded-lg p-3">
                                    <div class="text-sm font-semibold text-gray-600">Hatástartam</div>
                                    <div class="text-lg font-bold text-purple-600">24 óra</div>
                                </div>
                                <div class="bg-gray-50 rounded-lg p-3">
                                    <div class="text-sm font-semibold text-gray-600">Adagolás</div>
                                    <div class="text-lg font-bold text-orange-600">Esti</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-r from-blue-50 to-indigo-50 rounded-xl shadow-lg p-6 border border-blue-200">
                        <h3 class="text-lg font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-prescription text-blue-600 mr-2"></i>
                            Adagolási útmutató
                        </h3>
                        <div class="space-y-2 text-sm">
                            <div class="flex items-center space-x-2">
                                <i class="fas fa-circle text-blue-500 text-xs"></i>
                                <span><strong>Dózis:</strong> 50 mg kapszula, napi 1×</span>
                            </div>
                            <div class="flex items-center space-x-2">
                                <i class="fas fa-circle text-blue-500 text-xs"></i>
                                <span><strong>Időzítés:</strong> Lefekvés előtt</span>
                            </div>
                            <div class="flex items-center space-x-2">
                                <i class="fas fa-circle text-blue-500 text-xs"></i>
                                <span><strong>Levodopával:</strong> ±1 óra eltéréssel</span>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <script>
        // Pharmacokinetics Chart
        const pharmaCanvas = document.getElementById('pharmaChart'); 
        if (pharmaCanvas) { 
            const pharmaCtx = pharmaCanvas.getContext('2d');
            new Chart(pharmaCtx, {
                type: 'line',
                data: {
                    labels: ['0', '2', '4', '6', '8', '12', '16', '20', '24'],
                    datasets: [{
                        label: 'Plazma koncentráció',
                        data: [0, 85, 100, 95, 88, 75, 60, 45, 30],
                        borderColor: '#3b82f6',
                        backgroundColor: 'rgba(59, 130, 246, 0.1)',
                        borderWidth: 3,
                        fill: true,
                        tension: 0.4
                    }, {
                        label: 'COMT gátlás (%)',
                        data: [0, 70, 90, 95, 93, 88, 80, 70, 55],
                        borderColor: '#10b981',
                        backgroundColor: 'rgba(16, 185, 129, 0.1)',
                        borderWidth: 3,
                        fill: true,
                        tension: 0.4
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: {
                            beginAtZero: true,
                            max: 100,
                            title: {
                                display: true,
                                text: 'Relatív érték (%)'
                            }
                        },
                        x: {
                            title: {
                                display: true,
                                text: 'Idő (óra)'
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            position: 'top',
                        },
                        tooltip: {
                            mode: 'index',
                            intersect: false,
                        }
                    }
                }
            });
        }
    </script>
</body>
</html>

<!DOCTYPE html>
<html lang="hu">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BIPARK I-II Vizsgálatok Eredményei</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        body { font-family: 'Inter', sans-serif; }
        .gradient-bg-slide3 {
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
        }
        .medical-accent {
            background: linear-gradient(90deg, #059669 0%, #10b981 100%);
        }
        .blue-accent {
            background: linear-gradient(90deg, #1e3a8a 0%, #3b82f6 100%);
        }
        .study-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fed7aa 100%);
        }
        .results-box {
            background: linear-gradient(135deg, #dcfce7 0%, #bbf7d0 100%);
        }
        .safety-box {
            background: linear-gradient(135deg, #dbeafe 0%, #bfdbfe 100%);
        }
    </style>
</head>
<body class="m-0 p-0">
    <div class="w-full gradient-bg-slide3" style="width: 1280px; min-height: 720px;">
        <div class="blue-accent h-16 flex items-center px-8">
            <div class="flex items-center space-x-4 text-white">
                <i class="fas fa-flask text-2xl"></i>
                <h1 class="text-2xl font-bold">BIPARK I-II Vizsgálatok Eredményei</h1>
            </div>
        </div>

        <div class="px-8 py-6">
            <div class="grid grid-cols-3 gap-6">
                <div class="space-y-6">
                    <div class="study-box rounded-xl shadow-lg p-6 border-l-4 border-orange-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-microscope text-orange-500 mr-3"></i>
                            Vizsgálati design
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-white bg-opacity-70 rounded-lg p-3">
                                <div class="font-semibold text-gray-700 mb-2">BIPARK-I</div>
                                <div class="text-xs text-gray-600 space-y-1">
                                    <div>• Fázis III, multicentrikus</div>
                                    <div>• Randomizált, kettős-vak</div>
                                    <div>• Placebó és entacapone kontroll</div>
                                    <div>• 14-15 hét</div>
                                    <div>• N = 600 beteg</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-70 rounded-lg p-3">
                                <div class="font-semibold text-gray-700 mb-2">BIPARK-II</div>
                                <div class="text-xs text-gray-600 space-y-1">
                                    <div>• Fázis III, multicentrikus</div>
                                    <div>• Randomizált, kettős-vak</div>
                                    <div>• Placebó kontroll</div>
                                    <div>• 14-15 hét</div>
                                    <div>• N = 427 beteg</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-blue-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-users text-blue-500 mr-3"></i>
                            Beteg demográfia
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="grid grid-cols-2 gap-3">
                                <div class="bg-gray-50 rounded-lg p-2">
                                    <div class="text-xs text-gray-600">Átlagéletkor</div>
                                    <div class="font-bold text-blue-600">64.5 év</div>
                                </div>
                                <div class="bg-gray-50 rounded-lg p-2">
                                    <div class="text-xs text-gray-600">Férfi/Nő</div>
                                    <div class="font-bold text-purple-600">60.4% / 39.6%</div>
                                </div>
                            </div>
                            <div class="grid grid-cols-2 gap-3">
                                <div class="bg-gray-50 rounded-lg p-2">
                                    <div class="text-xs text-gray-600">PD időtartam</div>
                                    <div class="font-bold text-green-600">7.6 év</div>
                                </div>
                                <div class="bg-gray-50 rounded-lg p-2">
                                    <div class="text-xs text-gray-600">L-DOPA kezelés</div>
                                    <div class="font-bold text-orange-600">6.3 év</div>
                                </div>
                            </div>
                            <div class="bg-gray-50 rounded-lg p-2">
                                <div class="text-xs text-gray-600">Kiindulási OFF-idő</div>
                                <div class="font-bold text-red-600">6.2 ± 2.0 óra/nap</div>
                            </div>
                        </div>
                    </div>

                    <div class="results-box rounded-xl shadow-lg p-6 border-l-4 border-green-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-target text-green-500 mr-3"></i>
                            Elsődleges végpont
                        </h2>
                        <div class="space-y-3">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="text-sm font-semibold text-gray-700 mb-2">
                                    Abszolút OFF-idő változása
                                </div>
                                <div class="text-xs text-gray-600">
                                    Kiindulástól a vizsgálat végéig<br>
                                    Betegnaplók alapján<br>
                                    Placebóhoz viszonyítva
                                </div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-6">
                    <div class="bg-white rounded-xl shadow-lg p-6">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-chart-bar text-blue-500 mr-3"></i>
                            OFF-idő csökkentés (perc/nap)
                        </h2>
                        <div style="height: 220px;">
                            <canvas id="efficacyChartBipark"></canvas> 
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-trophy text-yellow-500 mr-3"></i>
                            Főbb eredmények
                        </h2>
                        <div class="space-y-4">
                            <div class="bg-green-50 border border-green-200 rounded-lg p-4">
                                <div class="text-lg font-bold text-green-700 mb-2">BIPARK-I</div>
                                <div class="text-sm text-gray-700 space-y-1">
                                    <div>• <strong>Opicapone 50mg:</strong> -60.8 perc OFF-idő csökkentés</div>
                                    <div>• <strong>vs. placebo:</strong> p &lt; 0.001</div>
                                    <div>• <strong>vs. entacapone:</strong> 51% nagyobb hatás</div>
                                </div>
                            </div>
                            <div class="bg-blue-50 border border-blue-200 rounded-lg p-4">
                                <div class="text-lg font-bold text-blue-700 mb-2">BIPARK-II</div>
                                <div class="text-sm text-gray-700 space-y-1">
                                    <div>• <strong>Opicapone 50mg:</strong> -54.3 perc OFF-idő csökkentés</div>
                                    <div>• <strong>vs. placebo:</strong> p &lt; 0.001</div>
                                    <div>• <strong>Konzisztens hatás</strong> mindkét vizsgálatban</div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-6">
                    <div class="safety-box rounded-xl shadow-lg p-6 border-l-4 border-blue-400">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-shield-alt text-blue-400 mr-3"></i>
                            Biztonságossági profil
                        </h2>
                        <div style="height: 200px;">
                            <canvas id="safetyChartBipark"></canvas> 
                        </div>
                        <div class="mt-4 space-y-2 text-sm">
                            <div class="flex justify-between">
                                <span class="text-gray-600">Dyskinesiaᵃ:</span>
                                <span class="font-semibold text-orange-600">16.5% vs 4.0%</span>
                            </div>
                            <div class="flex justify-between">
                                <span class="text-gray-600">Száj szárazság:</span>
                                <span class="font-semibold text-blue-600">3.8% vs 0.4%</span>
                            </div>
                            <div class="flex justify-between">
                                <span class="text-gray-600">Hányinger:</span>
                                <span class="font-semibold text-green-600">3.4% vs 1.8%</span>
                            </div>
                            <div class="text-xs text-gray-500 mt-2">
                                ᵃ L-DOPA bioelérhetőség növekedés miatt
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-purple-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-plus-circle text-purple-500 mr-3"></i>
                            Másodlagos végpontok
                        </h2>
                        <div class="space-y-4 text-sm">
                            <div class="bg-purple-50 rounded-lg p-3">
                                <div class="font-semibold text-purple-700 mb-2">ON-idő növekedés</div>
                                <div class="text-gray-700">+59.2 perc (BIPARK-I)</div>
                                <div class="text-gray-700">+52.6 perc (BIPARK-II)</div>
                            </div>
                            <div class="bg-indigo-50 rounded-lg p-3">
                                <div class="font-semibold text-indigo-700 mb-2">CGI-I javulás</div>
                                <div class="text-gray-700">Szignifikáns javulás</div>
                                <div class="text-gray-700">Orvos és beteg értékelés</div>
                            </div>
                            <div class="bg-green-50 rounded-lg p-3">
                                <div class="font-semibold text-green-700 mb-2">UPDRS-III score</div>
                                <div class="text-gray-700">Tendencia jellegű javulás</div>
                                <div class="text-gray-700">ON állapotban</div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-r from-gray-50 to-gray-100 rounded-xl shadow-lg p-6 border border-gray-300">
                        <h3 class="text-lg font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-calculator text-gray-600 mr-2"></i>
                            Statisztikai összefoglaló
                        </h3>
                        <div class="grid grid-cols-2 gap-3 text-xs">
                            <div class="bg-white rounded-lg p-3">
                                <div class="font-semibold text-gray-600">Hatásméret</div>
                                <div class="text-lg font-bold text-blue-600">Nagy</div>
                            </div>
                            <div class="bg-white rounded-lg p-3">
                                <div class="font-semibold text-gray-600">NNT</div>
                                <div class="text-lg font-bold text-green-600">~3-4</div>
                            </div>
                            <div class="bg-white rounded-lg p-3">
                                <div class="font-semibold text-gray-600">Dropout</div>
                                <div class="text-lg font-bold text-orange-600">&lt;10%</div>
                            </div>
                            <div class="bg-white rounded-lg p-3">
                                <div class="font-semibold text-gray-600">Konzisztencia</div>
                                <div class="text-lg font-bold text-purple-600">Magas</div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <script>
        // Efficacy Chart for BIPARK
        const efficacyBiparkCanvas = document.getElementById('efficacyChartBipark');
        if (efficacyBiparkCanvas) {
            const efficacyBiparkCtx = efficacyBiparkCanvas.getContext('2d');
            new Chart(efficacyBiparkCtx, {
                type: 'bar',
                data: {
                    labels: ['Placebo', 'Opicapone 25mg', 'Opicapone 50mg', 'Entacapone'],
                    datasets: [{
                        label: 'BIPARK-I',
                        data: [-23, -44, -61, -40],
                        backgroundColor: '#3b82f6',
                        borderColor: '#1d4ed8',
                        borderWidth: 1
                    }, {
                        label: 'BIPARK-II',
                        data: [-15, -35, -54, null], 
                        backgroundColor: '#10b981',
                        borderColor: '#047857',
                        borderWidth: 1
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: {
                            beginAtZero: true,
                            min: -70,
                            max: 0,
                            title: {
                                display: true,
                                text: 'OFF-idő változás (perc)'
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            position: 'top',
                        },
                        tooltip: {
                            callbacks: {
                                label: function(context) {
                                    return context.dataset.label + ': ' + Math.abs(context.parsed.y) + ' perc csökkentés';
                                }
                            }
                        }
                    }
                }
            });
        }

        // Safety Chart for BIPARK
        const safetyBiparkCanvas = document.getElementById('safetyChartBipark');
        if (safetyBiparkCanvas) {
            const safetyBiparkCtx = safetyBiparkCanvas.getContext('2d');
            new Chart(safetyBiparkCtx, {
                type: 'doughnut',
                data: {
                    labels: ['Dyskinesiaᵃ', 'Száj szárazság', 'Hányinger', 'Egyéb TEAE', 'Mellékhatás nélkül'],
                    datasets: [{
                        data: [16.5, 3.8, 3.4, 8.3, 68], 
                        backgroundColor: [
                            '#f59e0b',
                            '#3b82f6',
                            '#10b981',
                            '#8b5cf6',
                            '#e5e7eb'
                        ],
                        borderWidth: 2,
                        borderColor: '#ffffff'
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    plugins: {
                        legend: {
                            position: 'bottom',
                            labels: {
                                fontSize: 10, 
                                usePointStyle: true
                            }
                        },
                        tooltip: {
                            callbacks: {
                                label: function(context) {
                                    return context.label + ': ' + context.parsed + '%';
                                }
                            }
                        }
                    }
                }
            });
        }
    </script>
</body>
</html>

<!DOCTYPE html>
<html lang="hu">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Klinikai Hatékonyság és Biztonságosság</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        body { font-family: 'Inter', sans-serif; }
        .gradient-bg-slide4 {
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
        }
        .medical-accent {
            background: linear-gradient(90deg, #059669 0%, #10b981 100%);
        }
        .blue-accent {
            background: linear-gradient(90deg, #1e3a8a 0%, #3b82f6 100%);
        }
        .real-world-box {
            background: linear-gradient(135deg, #ecfdf5 0%, #d1fae5 100%);
        }
        .safety-box-klinikai { 
            background: linear-gradient(135deg, #fef3c7 0%, #fde68a 100%);
        }
        .longterm-box {
            background: linear-gradient(135deg, #e0e7ff 0%, #c7d2fe 100%);
        }
    </style>
</head>
<body class="m-0 p-0">
    <div class="w-full gradient-bg-slide4" style="width: 1280px; min-height: 720px;">
        <div class="blue-accent h-16 flex items-center px-8">
            <div class="flex items-center space-x-4 text-white">
                <i class="fas fa-chart-line text-2xl"></i>
                <h1 class="text-2xl font-bold">Klinikai Hatékonyság és Biztonságosság</h1>
            </div>
        </div>

        <div class="px-8 py-6">
            <div class="grid grid-cols-3 gap-6">
                <div class="space-y-6">
                    <div class="real-world-box rounded-xl shadow-lg p-6 border-l-4 border-green-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-globe text-green-500 mr-3"></i>
                            Real-world evidenciák
                        </h2>
                        <div class="space-y-4">
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-green-700 mb-2">OPTIPARK vizsgálat</div>
                                <div class="text-sm text-gray-700 space-y-1">
                                    <div>• <strong>n = 393</strong> beteg, 15 ország</div>
                                    <div>• <strong>-62.8 perc</strong> OFF-idő csökkentés</div>
                                    <div>• <strong>12 hónapos</strong> követés</div>
                                    <div>• <strong>93.6%</strong> beteg folytatta</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-blue-700 mb-2">UAE Real-World Study</div>
                                <div class="text-sm text-gray-700 space-y-1">
                                    <div>• <strong>Emirati és nem-fehér</strong> populáció</div>
                                    <div>• <strong>Konzisztens hatékonyság</strong></div>
                                    <div>• <strong>Jó tolerálhatóság</strong></div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="longterm-box rounded-xl shadow-lg p-6 border-l-4 border-indigo-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-clock text-indigo-500 mr-3"></i>
                            Hosszú távú hatékonyság
                        </h2>
                        <div style="height: 200px;">
                            <canvas id="longtermChart"></canvas>
                        </div>
                        <div class="mt-4 text-sm text-gray-700">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold mb-2">Fenntartott hatás</div>
                                <div class="space-y-1">
                                    <div>• <strong>Tartós OFF-idő csökkentés</strong></div>
                                    <div>• <strong>Nincs tolerancia kialakulás</strong></div>
                                    <div>• <strong>Stabil motor funkció javulás</strong></div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-purple-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-user-check text-purple-500 mr-3"></i>
                            Beteg-riportált eredmények
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="flex items-center justify-between bg-gray-50 rounded-lg p-3">
                                <span class="text-gray-700">Életminőség javulás</span>
                                <span class="font-bold text-green-600">+15-25%</span>
                            </div>
                            <div class="flex items-center justify-between bg-gray-50 rounded-lg p-3">
                                <span class="text-gray-700">Napi aktivitás</span>
                                <span class="font-bold text-blue-600">Javulás</span>
                            </div>
                            <div class="flex items-center justify-between bg-gray-50 rounded-lg p-3">
                                <span class="text-gray-700">Alvás minőség</span>
                                <span class="font-bold text-purple-600">Javulás</span>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-6">
                    <div class="bg-white rounded-xl shadow-lg p-6">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-shield-alt text-blue-500 mr-3"></i>
                            Biztonságossági profil
                        </h2>
                        <div style="height: 240px;">
                            <canvas id="safetyOverviewChart"></canvas>
                        </div>
                        <div class="mt-4 text-xs text-gray-600">
                            Pooled analysis (BIPARK I+II + hosszú távú vizsgálatok)
                        </div>
                    </div>

                    <div class="safety-box-klinikai rounded-xl shadow-lg p-6 border-l-4 border-yellow-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-exclamation-triangle text-yellow-500 mr-3"></i>
                            Gyakori mellékhatások
                        </h2>
                        <div class="space-y-3">
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="flex items-center justify-between mb-2">
                                    <span class="font-semibold text-orange-700">Dyskinesiaᵃ</span>
                                    <span class="text-lg font-bold text-orange-600">16.5%</span>
                                </div>
                                <div class="text-xs text-gray-600">
                                    L-DOPA bioelérhetőség növekedés miatt
                                </div>
                                <div class="w-full bg-gray-200 rounded-full h-2 mt-2">
                                    <div class="bg-red-500 h-2 rounded-full" style="width: 16.5%"></div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="flex items-center justify-between mb-2">
                                    <span class="font-semibold text-blue-700">Száj szárazság</span>
                                    <span class="text-lg font-bold text-blue-600">3.8%</span>
                                </div>
                                <div class="w-full bg-gray-200 rounded-full h-2">
                                    <div class="bg-blue-500 h-2 rounded-full" style="width: 3.8%"></div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="flex items-center justify-between mb-2">
                                    <span class="font-semibold text-green-700">Hányinger</span>
                                    <span class="text-lg font-bold text-green-600">3.4%</span>
                                </div>
                                <div class="w-full bg-gray-200 rounded-full h-2">
                                    <div class="bg-green-500 h-2 rounded-full" style="width: 3.4%"></div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-red-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-stop-circle text-red-500 mr-3"></i>
                            Kezelés megszakítás
                        </h2>
                        <div class="grid grid-cols-2 gap-4">
                            <div class="bg-red-50 rounded-lg p-3 text-center">
                                <div class="text-2xl font-bold text-red-600">7.6%</div>
                                <div class="text-sm text-gray-600">Mellékhatás miatt</div>
                            </div>
                            <div class="bg-green-50 rounded-lg p-3 text-center">
                                <div class="text-2xl font-bold text-green-600">92.4%</div>
                                <div class="text-sm text-gray-600">Folytatta kezelést</div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-6">
                    <div class="bg-white rounded-xl shadow-lg p-6">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-balance-scale text-purple-500 mr-3"></i>
                            COMT inhibitorok összehasonlítása
                        </h2>
                        <div style="height: 200px;">
                            <canvas id="comparativeChart"></canvas>
                        </div>
                        <div class="mt-4 space-y-2 text-sm">
                            <div class="flex items-center space-x-2">
                                <i class="fas fa-check-circle text-green-500"></i>
                                <span><strong>Opicapone:</strong> Nincs hepatotoxicitás</span>
                            </div>
                            <div class="flex items-center space-x-2">
                                <i class="fas fa-check-circle text-green-500"></i>
                                <span><strong>Opicapone:</strong> Nincs vizelet elszíneződés</span>
                            </div>
                            <div class="flex items-center space-x-2">
                                <i class="fas fa-times-circle text-red-500"></i>
                                <span><strong>Tolcapone:</strong> Májfunkció monitorizálás</span>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-br from-orange-50 to-red-50 rounded-xl shadow-lg p-6 border border-orange-200">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-warning text-orange-500 mr-3"></i>
                            Kockázati tényezők
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-orange-700 mb-2">Fokozott dyskinesiaᵃ kockázat:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• Hosszabb PD időtartam (>7 év)</div>
                                    <div>• Magasabb L-DOPA dózis (>600 mg/nap)</div>
                                    <div>• Korábbi dyskinesiaᵃ anamnézis</div>
                                    <div>• Fiatalabb életkor (&lt;60 év)</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-blue-700 mb-2">Jobb tolerálhatóság:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• Korai PD stádium</div>
                                    <div>• Friss motor fluktuációk (&lt;2 év)</div>
                                    <div>• Alacsonyabb L-DOPA dózis</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-br from-blue-50 to-indigo-50 rounded-xl shadow-lg p-6 border border-blue-200">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-user-md text-blue-500 mr-3"></i>
                            Biztonságossági menedzsment
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-blue-700 mb-2">Dyskinesiaᵃ esetén:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• L-DOPA dózis csökkentése</div>
                                    <div>• Adagolási gyakoriság módosítása</div>
                                    <div>• Opicapone folytatása lehetséges</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-green-700 mb-2">Monitorizálás:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• <strong>Nincs</strong> májfunkció ellenőrzés</div>
                                    <div>• Rendszeres motor státusz</div>
                                    <div>• Mellékhatások követése</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-green-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-heart text-green-500 mr-2"></i>
                            Életminőség hatás
                        </h2>
                        <div class="grid grid-cols-3 gap-2 text-xs">
                            <div class="bg-green-50 rounded-lg p-2 text-center">
                                <div class="text-lg font-bold text-green-600">↑</div>
                                <div class="text-gray-600">Mobilitás</div>
                            </div>
                            <div class="bg-blue-50 rounded-lg p-2 text-center">
                                <div class="text-lg font-bold text-blue-600">↑</div>
                                <div class="text-gray-600">ADL</div>
                            </div>
                            <div class="bg-purple-50 rounded-lg p-2 text-center">
                                <div class="text-lg font-bold text-purple-600">↑</div>
                                <div class="text-gray-600">Kommunikáció</div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <script>
        // Long-term Efficacy Chart
        const longtermCanvas = document.getElementById('longtermChart');
        if (longtermCanvas) {
            const longtermCtx = longtermCanvas.getContext('2d');
            new Chart(longtermCtx, {
                type: 'line',
                data: {
                    labels: ['Baseline', '3 hónap', '6 hónap', '12 hónap', '18 hónap'],
                    datasets: [{
                        label: 'OFF-idő csökkentés (perc)',
                        data: [0, -58, -62, -65, -63],
                        borderColor: '#10b981',
                        backgroundColor: 'rgba(16, 185, 129, 0.1)',
                        borderWidth: 3,
                        fill: true,
                        tension: 0.3
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: {
                            beginAtZero: true, 
                            min: -80, 
                            max: 10,
                            title: {
                                display: true,
                                text: 'OFF-idő változás (perc)'
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            display: false 
                        }
                    }
                }
            });
        }

        // Safety Overview Chart
        const safetyOverviewCanvas = document.getElementById('safetyOverviewChart');
        if (safetyOverviewCanvas) {
            const safetyOverviewCtx = safetyOverviewCanvas.getContext('2d'); 
            new Chart(safetyOverviewCtx, {
                type: 'bar',
                data: {
                    labels: ['Dyskinesiaᵃ', 'Száj szárazság', 'Hányinger', 'Szédülés', 'Hasmenés'],
                    datasets: [{
                        label: 'Opicapone (%)',
                        data: [16.5, 3.8, 3.4, 2.1, 1.2],
                        backgroundColor: '#3b82f6'
                    }, {
                        label: 'Placebo (%)',
                        data: [4.0, 0.4, 1.8, 1.2, 0.8],
                        backgroundColor: '#e5e7eb'
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: {
                            beginAtZero: true,
                            max: 20,
                            title: {
                                display: true,
                                text: 'Előfordulás (%)'
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            position: 'top',
                        }
                    }
                }
            });
        }

        // Comparative Safety Chart
        const comparativeCanvas = document.getElementById('comparativeChart');
        if (comparativeCanvas) {
            const comparativeCtx = comparativeCanvas.getContext('2d');
            new Chart(comparativeCtx, {
                type: 'radar',
                data: {
                    labels: ['Hatékonyság', 'Tolerálhatóság', 'Compliance', 'Hepatotoxicitás', 'Praktikusság'],
                    datasets: [{
                        label: 'Opicapone',
                        data: [9, 8, 9, 10, 9],
                        borderColor: '#10b981',
                        backgroundColor: 'rgba(16, 185, 129, 0.2)',
                        borderWidth: 2
                    }, {
                        label: 'Entacapone',
                        data: [7, 7, 6, 10, 5],
                        borderColor: '#3b82f6',
                        backgroundColor: 'rgba(59, 130, 246, 0.2)',
                        borderWidth: 2
                    }, {
                        label: 'Tolcapone',
                        data: [8, 6, 7, 3, 6],
                        borderColor: '#f59e0b',
                        backgroundColor: 'rgba(245, 158, 11, 0.2)',
                        borderWidth: 2
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        r: {
                            beginAtZero: true,
                            max: 10,
                            ticks: {
                                stepSize: 2
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            position: 'bottom',
                            labels: {
                                fontSize: 10 
                            }
                        }
                    }
                }
            });
        }
    </script>
</body>
</html>

<!DOCTYPE html>
<html lang="hu">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Praktikus Alkalmazási Útmutató</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        body { font-family: 'Inter', sans-serif; }
        .gradient-bg-slide5 {
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
        }
        .medical-accent {
            background: linear-gradient(90deg, #059669 0%, #10b981 100%);
        }
        .blue-accent {
            background: linear-gradient(90deg, #1e3a8a 0%, #3b82f6 100%);
        }
        .initiation-box {
            background: linear-gradient(135deg, #ecfdf5 0%, #d1fae5 100%);
        }
        .dosing-box {
            background: linear-gradient(135deg, #dbeafe 0%, #bfdbfe 100%);
        }
        .monitoring-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fde68a 100%);
        }
        .warning-box {
            background: linear-gradient(135deg, #fee2e2 0%, #fecaca 100%);
        }
        .step-indicator {
            width: 30px;
            height: 30px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: bold;
            color: white;
        }
        .timeline-line {
            width: 2px;
            height: 40px;
            background: linear-gradient(to bottom, #3b82f6, #e5e7eb);
            margin: 0 auto;
        }
    </style>
</head>
<body class="m-0 p-0">
    <div class="w-full gradient-bg-slide5" style="width: 1280px; min-height: 720px;">
        <div class="blue-accent h-16 flex items-center px-8">
            <div class="flex items-center space-x-4 text-white">
                <i class="fas fa-user-md text-2xl"></i>
                <h1 class="text-2xl font-bold">Praktikus Alkalmazási Útmutató</h1>
            </div>
        </div>

        <div class="px-8 py-6">
            <div class="grid grid-cols-3 gap-6">
                <div class="space-y-6">
                    <div class="initiation-box rounded-xl shadow-lg p-6 border-l-4 border-green-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-user-check text-green-500 mr-3"></i>
                            Betegkiválasztás
                        </h2>
                        <div class="space-y-4">
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-green-700 mb-3 flex items-center">
                                    <i class="fas fa-check-circle text-green-500 mr-2"></i>
                                    Indikációk
                                </div>
                                <div class="text-sm text-gray-700 space-y-2">
                                    <div>• <strong>End-of-dose</strong> wearing-off</div>
                                    <div>• <strong>Predictable OFF</strong> epizódok</div>
                                    <div>• <strong>≥3 óra OFF-idő/nap</strong></div>
                                    <div>• <strong>Stabil L-DOPA</strong> kezelés ≥1 év</div>
                                    <div>• <strong>Optimalizált</strong> L-DOPA dózis</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-blue-700 mb-3 flex items-center">
                                    <i class="fas fa-star text-blue-500 mr-2"></i>
                                    Ideális betegprofil
                                </div>
                                <div class="text-sm text-gray-700 space-y-2">
                                    <div>• <strong>Korai motor fluktuáció</strong> (&lt;2 év)</div>
                                    <div>• <strong>Alacsonyabb L-DOPA dózis</strong> (&lt;600 mg)</div>
                                    <div>• <strong>Jó compliance</strong></div>
                                    <div>• <strong>Nincs súlyos dyskinesiaᵃ</strong></div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="warning-box rounded-xl shadow-lg p-6 border-l-4 border-red-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-exclamation-triangle text-red-500 mr-3"></i>
                            Ellenjavallatok
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-red-700 mb-2">Abszolút:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• Túlérzékenység</div>
                                    <div>• Feokromocitóma</div>
                                    <div>• Súlyos hepatopathia</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-orange-700 mb-2">Relatív óvatosság:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• Súlyos dyskinesiaᵃ</div>
                                    <div>• Pszichózis anamnézis</div>
                                    <div>• Impulzus kontroll zavar</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-purple-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-clipboard-check text-purple-500 mr-3"></i>
                            Iniciálás előtti értékelés
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-book text-blue-500 mt-1"></i>
                                <div>
                                    <div class="font-semibold">Naplóvezetés</div>
                                    <div class="text-gray-600">7 napos ON/OFF státusz</div>
                                </div>
                            </div>
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-pills text-green-500 mt-1"></i>
                                <div>
                                    <div class="font-semibold">Gyógyszerek áttekintése</div>
                                    <div class="text-gray-600">L-DOPA optimalizálás</div>
                                </div>
                            </div>
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-heartbeat text-red-500 mt-1"></i>
                                <div>
                                    <div class="font-semibold">Alapvizsgálatok</div>
                                    <div class="text-gray-600">Vitális paraméterek, EKG</div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-6">
                    <div class="dosing-box rounded-xl shadow-lg p-6 border-l-4 border-blue-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-prescription-bottle text-blue-500 mr-3"></i>
                            Dózisbeállítás és adagolás
                        </h2>
                        <div class="space-y-4">
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="text-center mb-4">
                                    <div class="text-3xl font-bold text-blue-600">50 mg</div>
                                    <div class="text-sm text-gray-600">naponta egyszer</div>
                                </div>
                                <div class="space-y-2 text-sm">
                                    <div class="flex items-center space-x-2">
                                        <i class="fas fa-clock text-blue-500"></i>
                                        <span><strong>Időzítés:</strong> Lefekvés előtt</span>
                                    </div>
                                    <div class="flex items-center space-x-2">
                                        <i class="fas fa-utensils text-green-500"></i>
                                        <span><strong>Étkezés:</strong> 1 óra előtt/után</span>
                                    </div>
                                    <div class="flex items-center space-x-2">
                                        <i class="fas fa-pills text-purple-500"></i>
                                        <span><strong>L-DOPA:</strong> Változatlan dózis</span>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-calendar-alt text-indigo-500 mr-3"></i>
                            Iniciálási protokoll
                        </h2>
                        <div class="space-y-4">
                            <div class="flex items-center space-x-4">
                                <div class="step-indicator bg-green-500">1</div>
                                <div class="flex-1">
                                    <div class="font-semibold text-gray-800">1. hét</div>
                                    <div class="text-sm text-gray-600">Opicapone 50mg indítása</div>
                                    <div class="text-xs text-gray-500">L-DOPA dózis változatlan</div>
                                </div>
                                <div class="text-sm text-blue-600 font-semibold">Kezdés</div>
                            </div>
                            <div class="timeline-line"></div>
                            
                            <div class="flex items-center space-x-4">
                                <div class="step-indicator bg-blue-500">2</div>
                                <div class="flex-1">
                                    <div class="font-semibold text-gray-800">2-4. hét</div>
                                    <div class="text-sm text-gray-600">Hatékonyság értékelése</div>
                                    <div class="text-xs text-gray-500">OFF-idő csökkentés, mellékhatások</div>
                                </div>
                                <div class="text-sm text-green-600 font-semibold">Monitoring</div>
                            </div>
                            <div class="timeline-line"></div>
                            
                            <div class="flex items-center space-x-4">
                                <div class="step-indicator bg-purple-500">3</div>
                                <div class="flex-1">
                                    <div class="font-semibold text-gray-800">6-8. hét</div>
                                    <div class="text-sm text-gray-600">Optimalizálás</div>
                                    <div class="text-xs text-gray-500">L-DOPA dózis finomhangolás</div>
                                </div>
                                <div class="text-sm text-purple-600 font-semibold">Titráció</div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-br from-yellow-50 to-orange-50 rounded-xl shadow-lg p-6 border border-yellow-200">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-clock text-orange-500 mr-3"></i>
                            Időzítési megfontolások
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-orange-700 mb-2">Miért lefekvés előtt?</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• <strong>24 órás</strong> COMT gátlás</div>
                                    <div>• <strong>Reggeli dózis</strong> védelem</div>
                                    <div>• <strong>Kevesebb</strong> nappali mellékhatás</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-blue-700 mb-2">Étkezéssel való interakció:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• Fehérje <strong>csökkenti</strong> bioelérhetőséget</div>
                                    <div>• <strong>Üres gyomorra</strong> optimális</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-gray-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-users text-gray-500 mr-3"></i>
                            Speciális populációk
                        </h2>
                        <div class="grid grid-cols-2 gap-3 text-sm">
                            <div class="bg-gray-50 rounded-lg p-3">
                                <div class="font-semibold text-gray-700 mb-1">Idősek</div>
                                <div class="text-gray-600">Normál dózis, fokozott monitoring</div>
                            </div>
                            <div class="bg-gray-50 rounded-lg p-3">
                                <div class="font-semibold text-gray-700 mb-1">Vesebetegség</div>
                                <div class="text-gray-600">Nincs dózismódosítás</div>
                            </div>
                            <div class="bg-gray-50 rounded-lg p-3">
                                <div class="font-semibold text-gray-700 mb-1">Májbetegség</div>
                                <div class="text-gray-600">Óvatosság, enyhe: normál dózis</div>
                            </div>
                            <div class="bg-gray-50 rounded-lg p-3">
                                <div class="font-semibold text-gray-700 mb-1">Terhesség</div>
                                <div class="text-gray-600">Nem ajánlott</div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-6">
                    <div class="monitoring-box rounded-xl shadow-lg p-6 border-l-4 border-yellow-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-heartbeat text-yellow-500 mr-3"></i>
                            Monitorozási protokoll
                        </h2>
                        <div class="space-y-4">
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-yellow-700 mb-3">Rutinellenőrzések</div>
                                <div class="space-y-2 text-sm">
                                    <div class="flex justify-between">
                                        <span class="text-gray-700">1-2. hét:</span>
                                        <span class="font-semibold text-blue-600">Telefon</span>
                                    </div>
                                    <div class="flex justify-between">
                                        <span class="text-gray-700">4. hét:</span>
                                        <span class="font-semibold text-green-600">Vizit</span>
                                    </div>
                                    <div class="flex justify-between">
                                        <span class="text-gray-700">3. hónap:</span>
                                        <span class="font-semibold text-purple-600">Értékelés</span>
                                    </div>
                                    <div class="flex justify-between">
                                        <span class="text-gray-700">6 hónap:</span>
                                        <span class="font-semibold text-indigo-600">Követés</span>
                                    </div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-green-700 mb-3">Mit kell figyelni?</div>
                                <div class="space-y-2 text-sm text-gray-700">
                                    <div>• <strong>OFF-idő</strong> csökkentés</div>
                                    <div>• <strong>Dyskinesiaᵃ</strong> változás</div>
                                    <div>• <strong>Compliance</strong></div>
                                    <div>• <strong>Mellékhatások</strong></div>
                                    <div>• <strong>Életminőség</strong></div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-stethoscope text-red-500 mr-3"></i>
                            Mellékhatás menedzsment
                        </h2>
                        <div style="height: 200px;">
                            <canvas id="sideEffectChartPraktikus"></canvas> 
                        </div>
                        <div class="mt-4 space-y-3 text-sm">
                            <div class="bg-orange-50 border border-orange-200 rounded-lg p-3">
                                <div class="font-semibold text-orange-700 mb-2">Dyskinesiaᵃ kezelése:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>1. L-DOPA dózis csökkentése 10-25%-kal</div>
                                    <div>2. Gyakoribb, kisebb adagok</div>
                                    <div>3. Opicapone folytatható</div>
                                </div>
                            </div>
                            <div class="bg-blue-50 border border-blue-200 rounded-lg p-3">
                                <div class="font-semibold text-blue-700 mb-2">Egyéb mellékhatások:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• <strong>Hányinger:</strong> Étkezéssel együtt</div>
                                    <div>• <strong>Száj szárazság:</strong> Folyadékbevitel ↑</div>
                                    <div>• <strong>Szédülés:</strong> Lassú felállás</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-br from-green-50 to-emerald-50 rounded-xl shadow-lg p-6 border border-green-200">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-trophy text-green-500 mr-3"></i>
                            Sikerkritériumok
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-green-700 mb-2">Hatékonyság jelei:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• ≥30 perc OFF-idő csökkentés</div>
                                    <div>• Reggeli akinézia javulás</div>
                                    <div>• Kevesebb "rescue" dózis</div>
                                    <div>• Életminőség javulás</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-blue-700 mb-2">Kezelés folytatása:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• Jó tolerálhatóság</div>
                                    <div>• Klinikailag releváns javulás</div>
                                    <div>• Beteg elégedettsége</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-br from-purple-50 to-indigo-50 rounded-xl shadow-lg p-6 border border-purple-200">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-lightbulb text-purple-500 mr-3"></i>
                            Gyakorlati tippek
                        </h2>
                        <div class="space-y-2 text-sm">
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-check-circle text-green-500 mt-1"></i>
                                <div class="text-gray-700">
                                    <strong>Betegoktatás:</strong> Magyarázza el a night-time dosing logikáját
                                </div>
                            </div>
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-check-circle text-blue-500 mt-1"></i>
                                <div class="text-gray-700">
                                    <strong>Naplóvezetés:</strong> ON/OFF státusz követése első hónapban
                                </div>
                            </div>
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-check-circle text-purple-500 mt-1"></i>
                                <div class="text-gray-700">
                                    <strong>Expectation management:</strong> 2-4 hét a teljes hatás
                                </div>
                            </div>
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-check-circle text-orange-500 mt-1"></i>
                                <div class="text-gray-700">
                                    <strong>Compliance:</strong> Emlékeztető alkalmazások ajánlása
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <script>
        // Side Effect Management Chart for Praktikus slide
        const sideEffectPraktikusCanvas = document.getElementById('sideEffectChartPraktikus');
        if (sideEffectPraktikusCanvas) {
            const sideEffectPraktikusCtx = sideEffectPraktikusCanvas.getContext('2d');
            new Chart(sideEffectPraktikusCtx, {
                type: 'bar',
                data: {
                    labels: ['Dyskinesiaᵃ', 'Száj szárazság', 'Hányinger', 'Szédülés'],
                    datasets: [{
                        label: 'Gyakoriság (%)',
                        data: [16.5, 3.8, 3.4, 2.1],
                        backgroundColor: ['#f59e0b', '#3b82f6', '#10b981', '#8b5cf6'],
                        borderColor: ['#d97706', '#1d4ed8', '#047857', '#7c3aed'],
                        borderWidth: 2
                    }, {
                        label: 'Kezelhetőség (1-10)',
                        data: [7, 9, 8, 8], 
                        type: 'line',
                        borderColor: '#ef4444',
                        backgroundColor: 'rgba(239, 68, 68, 0.1)',
                        borderWidth: 3,
                        yAxisID: 'y1', 
                        tension: 0.3
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: { 
                            beginAtZero: true,
                            max: 20,
                            title: {
                                display: true,
                                text: 'Előfordulás (%)'
                            }
                        },
                        y1: { 
                            type: 'linear',
                            display: true,
                            position: 'right',
                            min: 0, 
                            max: 10,
                            title: {
                                display: true,
                                text: 'Kezelhetőség (1-10)'
                            },
                            grid: {
                                drawOnChartArea: false, 
                            },
                        }
                    },
                    plugins: {
                        legend: {
                            position: 'top',
                            labels: {
                                fontSize: 10 
                            }
                        },
                        tooltip: {
                            callbacks: {
                                label: function(context) {
                                    if (context.datasetIndex === 0) {
                                        return 'Gyakoriság: ' + context.parsed.y + '%';
                                    } else {
                                        return 'Kezelhetőség: ' + context.parsed.y + '/10';
                                    }
                                }
                            }
                        }
                    }
                }
            });
        }
    </script>
</body>
</html>

<!DOCTYPE html>
<html lang="hu">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Kombinációs Kezelések</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        body { font-family: 'Inter', sans-serif; }
        .gradient-bg-slide6 {
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
        }
        .blue-accent {
            background: linear-gradient(90deg, #1e3a8a 0%, #3b82f6 100%);
        }
        .levodopa-box {
            background: linear-gradient(135deg, #ecfdf5 0%, #d1fae5 100%);
        }
        .da-box {
            background: linear-gradient(135deg, #dbeafe 0%, #bfdbfe 100%);
        }
        .device-box {
            background: linear-gradient(135deg, #f3e8ff 0%, #e9d5ff 100%);
        }
        .evidence-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fde68a 100%);
        }
    </style>
</head>
<body class="m-0 p-0">
    <div class="w-full gradient-bg-slide6" style="width: 1280px; min-height: 720px;">
        <div class="blue-accent h-16 flex items-center px-8">
            <div class="flex items-center space-x-4 text-white">
                <i class="fas fa-layer-group text-2xl"></i>
                <h1 class="text-2xl font-bold">Kombinációs Kezelések</h1>
            </div>
        </div>

        <div class="px-8 py-6">
            <div class="grid grid-cols-3 gap-6">
                <div class="space-y-6">
                    <div class="levodopa-box rounded-xl shadow-lg p-6 border-l-4 border-green-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-pills text-green-500 mr-3"></i>
                            Levodopa kombináció
                        </h2>
                        <div class="space-y-4">
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-green-700 mb-3">Standard alkalmazás</div>
                                <div class="text-sm text-gray-700 space-y-2">
                                    <div>• <strong>L-DOPA/DDCI</strong> mellett adjuváns</div>
                                    <div>• <strong>Bioelérhetőség ↑</strong> 15-30%</div>
                                    <div>• <strong>Felezési idő ↑</strong> 1.5-2x</div>
                                    <div>• <strong>OFF-idő ↓</strong> 60-90 perc/nap</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-blue-700 mb-3">Dózis optimalizálás</div>
                                <div class="text-sm text-gray-700 space-y-2">
                                    <div>• <strong>Kezdetben:</strong> L-DOPA dózis változatlan</div>
                                    <div>• <strong>Dyskinesiaᵃ esetén:</strong> L-DOPA ↓ 10-25%</div>
                                    <div>• <strong>Gyakoriság:</strong> Változatlan vagy ↓</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="da-box rounded-xl shadow-lg p-6 border-l-4 border-blue-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-atom text-blue-500 mr-3"></i>
                            Dopamin agonista kombináció
                        </h2>
                        <div class="space-y-4">
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-blue-700 mb-3">Kompatibilitás</div>
                                <div class="text-sm text-gray-700 space-y-1">
                                    <div>• <strong>Ropinirol:</strong> Biztonságos</div>
                                    <div>• <strong>Pramipexol:</strong> Biztonságos</div>
                                    <div>• <strong>Rotigotine:</strong> Biztonságos</div>
                                    <div>• <strong>Apomorphine:</strong> Speciális figyelem</div>
                                </div>
                            </div>
                            <div style="height: 120px;">
                                <canvas id="combinationChartKombinacios"></canvas> 
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-orange-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-exclamation-triangle text-orange-500 mr-3"></i>
                            Gyógyszerkölcsönhatások
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-red-50 border border-red-200 rounded-lg p-3">
                                <div class="font-semibold text-red-700 mb-2">Kerülendő:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• <strong>MAOI:</strong> Tyramine válság</div>
                                    <div>• <strong>Antipsychotikumok:</strong> ↓ Hatékonyság</div>
                                </div>
                            </div>
                            <div class="bg-yellow-50 border border-yellow-200 rounded-lg p-3">
                                <div class="font-semibold text-yellow-700 mb-2">Óvatosság:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• <strong>Warfarin:</strong> INR monitoring</div>
                                    <div>• <strong>Metoclopramid:</strong> ↓ Motilitás</div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-6">
                    <div class="device-box rounded-xl shadow-lg p-6 border-l-4 border-purple-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-brain text-purple-500 mr-3"></i>
                            Deep Brain Stimulation (DBS)
                        </h2>
                        <div class="space-y-4">
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-purple-700 mb-3">Kombinációs előnyök</div>
                                <div class="text-sm text-gray-700 space-y-2">
                                    <div>• <strong>Additív hatás</strong> motor tünetekre</div>
                                    <div>• <strong>L-DOPA dózis ↓</strong> DBS után</div>
                                    <div>• <strong>Opicapone</strong> továbbra hasznos</div>
                                    <div>• <strong>OFF epizódok</strong> további csökkenése</div>
                                </div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-4">
                                <div class="font-semibold text-indigo-700 mb-3">Praktikus szempontok</div>
                                <div class="text-sm text-gray-700 space-y-2">
                                    <div>• <strong>Pre-DBS:</strong> Optimalizálás</div>
                                    <div>• <strong>Post-DBS:</strong> Fokozatos titrálás</div>
                                    <div>• <strong>Monitoring:</strong> Intensívebb</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-syringe text-indigo-500 mr-3"></i>
                            Pumpa terápiák
                        </h2>
                        <div style="height: 200px;">
                            <canvas id="deviceChartKombinacios"></canvas> 
                        </div>
                        <div class="mt-4 space-y-3 text-sm">
                            <div class="bg-blue-50 border border-blue-200 rounded-lg p-3">
                                <div class="font-semibold text-blue-700 mb-2">LCIG (Duodopa®):</div>
                                <div class="text-gray-700">
                                    • Átmenet során opicapone segíthet<br>
                                    • Jejunalis pump optimalizálás alatt
                                </div>
                            </div>
                            <div class="bg-green-50 border border-green-200 rounded-lg p-3">
                                <div class="font-semibold text-green-700 mb-2">Apomorphine pumpa:</div>
                                <div class="text-gray-700">
                                    • Kombinálható biztonságosan<br>
                                    • Szinergista hatás lehetséges
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-br from-gray-50 to-blue-50 rounded-xl shadow-lg p-6 border border-gray-200">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-cogs text-gray-500 mr-3"></i>
                            Egyéb fejlett terápiák
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-gray-700 mb-2">Focused Ultrasound:</div>
                                <div class="text-gray-600">Limited data, theoretically compatible</div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-gray-700 mb-2">Gene Therapy:</div>
                                <div class="text-gray-600">Future combination potential</div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-gray-700 mb-2">Cell Therapy:</div>
                                <div class="text-gray-600">Research stage combinations</div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-6">
                    <div class="evidence-box rounded-xl shadow-lg p-6 border-l-4 border-yellow-500">
                        <h2 class="text-xl font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-chart-bar text-yellow-500 mr-3"></i>
                            Klinikai evidenciák
                        </h2>
                        <div style="height: 180px;">
                            <canvas id="evidenceChartKombinacios"></canvas> 
                        </div>
                        <div class="mt-4 space-y-3 text-sm">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-yellow-700 mb-2">Post-hoc análizis:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• <strong>DA + Opicapone:</strong> Jobb tolerálhatóság</div>
                                    <div>• <strong>Monoterápia:</strong> Fokozott dyskinesiaᵃ</div>
                                    <div>• <strong>Korai kombináció:</strong> Előnyös</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-6 border-l-4 border-indigo-500">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-chess text-indigo-500 mr-3"></i>
                            Optimalizálási stratégiák
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-indigo-50 border border-indigo-200 rounded-lg p-3">
                                <div class="font-semibold text-indigo-700 mb-2">Bevezetési sorrend:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>1. <strong>L-DOPA optimalizálás</strong></div>
                                    <div>2. <strong>Opicapone hozzáadás</strong></div>
                                    <div>3. <strong>DA agonista finomhangolás</strong></div>
                                    <div>4. <strong>Device therapy mérlegelés</strong></div>
                                </div>
                            </div>
                            <div class="bg-green-50 border border-green-200 rounded-lg p-3">
                                <div class="font-semibold text-green-700 mb-2">Monitoring fokozat:</div>
                                <div class="text-gray-700 space-y-1">
                                    <div>• <strong>Kombinált terápia:</strong> ↑ Gyakoriság</div>
                                    <div>• <strong>Mellékhatások:</strong> Additív kockázat</div>
                                    <div>• <strong>Költséghatékonyság:</strong> Értékelés</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-br from-purple-50 to-pink-50 rounded-xl shadow-lg p-6 border border-purple-200">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-route text-purple-500 mr-3"></i>
                            Döntési algoritmus
                        </h2>
                        <div class="space-y-3 text-sm">
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-purple-700 mb-2">Korai stádium:</div>
                                <div class="text-gray-700">L-DOPA + Opicapone kombinációval kezdés</div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-blue-700 mb-2">Középhaladó:</div>
                                <div class="text-gray-700">+ DA agonista vagy MAO-B inhibitor</div>
                            </div>
                            <div class="bg-white bg-opacity-80 rounded-lg p-3">
                                <div class="font-semibold text-orange-700 mb-2">Haladó stádium:</div>
                                <div class="text-gray-700">Device therapy + optimalizált orális kezelés</div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-gradient-to-br from-red-50 to-orange-50 rounded-xl shadow-lg p-6 border border-red-200">
                        <h2 class="text-lg font-bold text-gray-800 mb-4 flex items-center">
                            <i class="fas fa-shield-alt text-red-500 mr-3"></i>
                            Biztonsági megfontolások
                        </h2>
                        <div class="space-y-2 text-sm">
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-exclamation-triangle text-red-500 mt-1"></i>
                                <div class="text-gray-700">
                                    <strong>Additív mellékhatások:</strong> Dyskinesiaᵃ, hypotensio
                                </div>
                            </div>
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-clock text-orange-500 mt-1"></i>
                                <div class="text-gray-700">
                                    <strong>Timing:</strong> Drug-device interakciók figyelése
                                </div>
                            </div>
                            <div class="flex items-start space-x-2">
                                <i class="fas fa-user-md text-blue-500 mt-1"></i>
                                <div class="text-gray-700">
                                    <strong>Expertise:</strong> Tapasztalt centrum szükséges
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <script>
        // Combination Efficacy Chart for Kombinacios slide
        const combinationKombinaciosCanvas = document.getElementById('combinationChartKombinacios');
        if (combinationKombinaciosCanvas) {
            const combinationKombinaciosCtx = combinationKombinaciosCanvas.getContext('2d');
            new Chart(combinationKombinaciosCtx, {
                type: 'bar',
                data: {
                    labels: ['Csak L-DOPA', '+ Opicapone', '+ DA agonista', 'Hármas kombináció'],
                    datasets: [{
                        label: 'OFF-idő csökkentés (%)',
                        data: [0, 25, 15, 35], 
                        backgroundColor: ['#e5e7eb', '#3b82f6', '#10b981', '#8b5cf6'],
                        borderColor: ['#9ca3af', '#1d4ed8', '#047857', '#7c3aed'],
                        borderWidth: 2
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: {
                            beginAtZero: true,
                            max: 40,
                            title: {
                                display: true,
                                text: 'Javulás (%)'
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            display: false
                        }
                    }
                }
            });
        }

        // Device Therapy Chart for Kombinacios slide
        const deviceKombinaciosCanvas = document.getElementById('deviceChartKombinacios');
        if (deviceKombinaciosCanvas) {
            const deviceKombinaciosCtx = deviceKombinaciosCanvas.getContext('2d');
            new Chart(deviceKombinaciosCtx, {
                type: 'radar',
                data: {
                    labels: ['Hatékonyság', 'Invasivitás', 'Költség', 'Compliance', 'QoL javulás'],
                    datasets: [{
                        label: 'DBS + Opicapone',
                        data: [9, 3, 3, 8, 9], 
                        borderColor: '#8b5cf6',
                        backgroundColor: 'rgba(139, 92, 246, 0.2)',
                        borderWidth: 2
                    }, {
                        label: 'LCIG + Opicapone',
                        data: [8, 5, 4, 7, 8], 
                        borderColor: '#3b82f6',
                        backgroundColor: 'rgba(59, 130, 246, 0.2)',
                        borderWidth: 2
                    }, {
                        label: 'Apomorphine + Opicapone',
                        data: [7, 6, 6, 6, 7], 
                        borderColor: '#10b981',
                        backgroundColor: 'rgba(16, 185, 129, 0.2)',
                        borderWidth: 2
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        r: {
                            beginAtZero: true,
                            max: 10,
                            ticks: {
                                stepSize: 2
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            position: 'bottom',
                            labels: {
                                fontSize: 8 
                            }
                        }
                    }
                }
            });
        }

        // Evidence Chart for Kombinacios slide
        const evidenceKombinaciosCanvas = document.getElementById('evidenceChartKombinacios');
        if (evidenceKombinaciosCanvas) {
            const evidenceKombinaciosCtx = evidenceKombinaciosCanvas.getContext('2d');
            new Chart(evidenceKombinaciosCtx, {
                type: 'line',
                data: {
                    labels: ['Baseline', '1 hónap', '3 hónap', '6 hónap', '12 hónap'],
                    datasets: [{
                        label: 'Monoterápia',
                        data: [6.2, 5.8, 5.9, 6.0, 6.1], 
                        borderColor: '#ef4444',
                        backgroundColor: 'rgba(239, 68, 68, 0.1)',
                        borderWidth: 2,
                        tension: 0.3
                    }, {
                        label: 'DA kombinálva',
                        data: [6.0, 4.8, 4.5, 4.3, 4.2], 
                        borderColor: '#3b82f6',
                        backgroundColor: 'rgba(59, 130, 246, 0.1)',
                        borderWidth: 2,
                        tension: 0.3
                    }, {
                        label: 'Device + Opicapone',
                        data: [5.8, 3.2, 2.8, 2.5, 2.3], 
                        borderColor: '#10b981',
                        backgroundColor: 'rgba(16, 185, 129, 0.1)',
                        borderWidth: 2,
                        tension: 0.3
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: {
                            beginAtZero: true, 
                            max: 7,
                            title: {
                                display: true,
                                text: 'OFF-idő (óra/nap)'
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            position: 'top',
                            labels: {
                                fontSize: 10 
                            }
                        }
                    }
                }
            });
        }
    </script>
</body>
</html>

<!DOCTYPE html>
<html lang="hu">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>COMT Inhibitorok Összehasonlítása</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        body { font-family: 'Inter', sans-serif; }
        .gradient-bg-slide7 {
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
        }
        .blue-accent {
            background: linear-gradient(90deg, #1e3a8a 0%, #3b82f6 100%);
        }
        .opicapone-box {
            background: linear-gradient(135deg, #ecfdf5 0%, #d1fae5 100%); 
        }
        .entacapone-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%); 
        }
        .tolcapone-box {
            background: linear-gradient(135deg, #fffbeb 0%, #fef3c7 100%); 
        }
        .comparison-table-bg {
            background: linear-gradient(135deg, #f9fafb 0%, #f3f4f6 100%);
        }
        .drug-card {
            transition: transform 0.2s ease, box-shadow 0.2s ease;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
        }
        .drug-card:hover {
            transform: translateY(-3px);
            box-shadow: 0 10px 15px rgba(0,0,0,0.1);
        }
        .table th, .table td {
            padding: 0.75rem;
            vertical-align: top;
            border-top: 1px solid #e5e7eb;
        }
        .table thead th {
            vertical-align: bottom;
            border-bottom: 2px solid #e5e7eb;
            background-color: #f9fafb;
        }
         .summary-recommendation-box {
            background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%);
        }
    </style>
</head>
<body class="m-0 p-0">
    <div class="w-full gradient-bg-slide7" style="width: 1280px; min-height: 720px;">
        <div class="blue-accent h-16 flex items-center px-8">
            <div class="flex items-center space-x-4 text-white">
                <i class="fas fa-balance-scale text-2xl"></i>
                <h1 class="text-2xl font-bold">COMT Inhibitorok Összehasonlítása</h1>
            </div>
        </div>

        <div class="px-6 py-4">
            <div class="grid grid-cols-3 gap-4">
                <div class="space-y-3">
                    <div class="opicapone-box rounded-xl p-4 border-l-4 border-green-600 drug-card">
                        <h2 class="text-lg font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-star text-green-600 mr-2"></i>
                            Opicapone (Ongentys®)
                        </h2>
                        <div class="space-y-2">
                            <div class="bg-white bg-opacity-70 rounded-lg p-3 text-sm">
                                <div class="flex justify-between"><span class="font-semibold text-green-700">Dózis:</span><span class="text-gray-700">50 mg</span></div>
                                <div class="flex justify-between"><span class="font-semibold text-green-700">Gyakoriság:</span><span class="text-gray-700">Naponta 1x</span></div>
                                <div class="flex justify-between"><span class="font-semibold text-green-700">Időzítés:</span><span class="text-gray-700">Lefekvéskor</span></div>
                                <div class="flex justify-between"><span class="font-semibold text-green-700">Felezési idő:</span><span class="text-gray-700">1-3 óra (klinikai hatás ~24ó)</span></div>
                            </div>
                            <div class="bg-white bg-opacity-70 rounded-lg p-3 text-xs">
                                <div class="font-semibold text-green-700 mb-1">Előnyök:</div>
                                <ul class="list-disc list-inside text-gray-700 space-y-1">
                                    <li>Kényelmes napi egyszeri adagolás</li>
                                    <li>Erőteljes és tartós COMT gátlás</li>
                                    <li>Nincs szükség májenzim monitorozásra</li>
                                    <li>Jobb adherencia potenciál</li>
                                    <li>Kisebb gasztrointesztinális mellékhatás profil</li>
                                </ul>
                            </div>
                        </div>
                    </div>

                    <div class="entacapone-box rounded-xl p-4 border-l-4 border-blue-600 drug-card">
                        <h2 class="text-lg font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-pills text-blue-600 mr-2"></i>
                            Entacapone (Comtan®/Comtess®)
                        </h2>
                        <div class="space-y-2">
                            <div class="bg-white bg-opacity-70 rounded-lg p-3 text-sm">
                                <div class="flex justify-between"><span class="font-semibold text-blue-700">Dózis:</span><span class="text-gray-700">200 mg</span></div>
                                <div class="flex justify-between"><span class="font-semibold text-blue-700">Gyakoriság:</span><span class="text-gray-700">Minden L-DOPA dózissal</span></div>
                                <div class="flex justify-between"><span class="font-semibold text-blue-700">Időzítés:</span><span class="text-gray-700">L-DOPA-val együtt</span></div>
                                <div class="flex justify-between"><span class="font-semibold text-blue-700">Felezési idő:</span><span class="text-gray-700">0.7-1.3 óra</span></div>
                            </div>
                            <div class="bg-white bg-opacity-70 rounded-lg p-3 text-xs">
                                <div class="font-semibold text-blue-700 mb-1">Jellemzők:</div>
                                <ul class="list-disc list-inside text-gray-700 space-y-1">
                                    <li>Jól ismert biztonságossági profil</li>
                                    <li>Kombinált készítmények elérhetők (Stalevo®)</li>
                                    <li>Széleskörű klinikai tapasztalat</li>
                                    <li>Vizelet narancssárgás elszíneződése</li>
                                </ul>
                            </div>
                        </div>
                    </div>

                    <div class="tolcapone-box rounded-xl p-4 border-l-4 border-yellow-500 drug-card">
                        <h2 class="text-lg font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-exclamation-triangle text-yellow-600 mr-2"></i>
                            Tolcapone (Tasmar®)
                        </h2>
                        <div class="space-y-2">
                            <div class="bg-white bg-opacity-70 rounded-lg p-3 text-sm">
                                <div class="flex justify-between"><span class="font-semibold text-yellow-700">Dózis:</span><span class="text-gray-700">100-200 mg</span></div>
                                <div class="flex justify-between"><span class="font-semibold text-yellow-700">Gyakoriság:</span><span class="text-gray-700">Naponta 3x</span></div>
                                <div class="flex justify-between"><span class="font-semibold text-yellow-700">Időzítés:</span><span class="text-gray-700">Rendszeres időközönként</span></div>
                                <div class="flex justify-between"><span class="font-semibold text-yellow-700">Felezési idő:</span><span class="text-gray-700">2-3 óra</span></div>
                            </div>
                            <div class="bg-white bg-opacity-70 rounded-lg p-3 text-xs">
                                <div class="font-semibold text-red-700 mb-1">Figyelmeztetés/Jellemzők:</div>
                                <ul class="list-disc list-inside text-gray-700 space-y-1">
                                    <li>Májenzim monitorozás kötelező (hepatotoxicitás)</li>
                                    <li>Potens COMT gátlás, centrális hatás is</li>
                                    <li>Korlátozottan elérhető, szigorú indikáció</li>
                                    <li>Hasmenés gyakori mellékhatás</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-3">
                    <div class="bg-white rounded-xl shadow-lg p-4 drug-card">
                        <h2 class="text-md font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-chart-line text-purple-500 mr-2"></i>
                            Hatékonyság: OFF-idő csökkentés
                        </h2>
                        <div style="height: 130px;"><canvas id="comtEfficacyChart"></canvas></div> 
                        <p class="text-xs text-gray-500 mt-1 text-center">Átlagos OFF-idő csökkenés placebóhoz képest (perc/nap)</p>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-4 drug-card">
                        <h2 class="text-md font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-shield-alt text-red-500 mr-2"></i>
                            Biztonsági és Tolerálhatósági Profil
                        </h2>
                        <div style="height: 130px;"><canvas id="comtSafetyChart"></canvas></div> 
                         <p class="text-xs text-gray-500 mt-1 text-center">Kulcsfontosságú mellékhatások és jellemzők</p>
                    </div>
                    
                    <div class="comparison-table-bg rounded-xl shadow-lg p-4 drug-card">
                        <h2 class="text-md font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-flask text-indigo-500 mr-2"></i>
                            Farmakokinetikai Összehasonlítás
                        </h2>
                        <div class="overflow-x-auto">
                            <table class="w-full text-xs table">
                                <thead>
                                    <tr>
                                        <th class="text-left">Paraméter</th>
                                        <th class="text-center text-green-700">Opicapone</th>
                                        <th class="text-center text-blue-700">Entacapone</th>
                                        <th class="text-center text-yellow-700">Tolcapone</th>
                                    </tr>
                                </thead>
                                <tbody class="text-gray-700">
                                    <tr><td>Tmax (óra)</td><td class="text-center">1-2</td><td class="text-center">0.5-1</td><td class="text-center">1-2</td></tr>
                                    <tr><td>Bioelérhetőség (%)</td><td class="text-center">~20</td><td class="text-center">~35</td><td class="text-center">~65</td></tr>
                                    <tr><td>CNS penetráció</td><td class="text-center">Minimális</td><td class="text-center">Minimális</td><td class="text-center">Jelentős</td></tr>
                                    <tr><td>Hatástartam (klinikai)</td><td class="text-center">~24 óra</td><td class="text-center">L-DOPA dózissal egyező</td><td class="text-center">~8-12 óra</td></tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </div>

                <div class="space-y-3">
                    <div class="bg-white rounded-xl shadow-lg p-4 drug-card">
                        <h2 class="text-md font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-user-md text-teal-500 mr-2"></i>
                            Klinikai Megfontolások és Választás
                        </h2>
                        <div class="text-xs space-y-2">
                            <div class="bg-green-50 p-2 rounded-lg">
                                <strong class="text-green-700">Opicapone:</strong>
                                <ul class="list-disc list-inside ml-2 text-gray-700">
                                    <li>Első választás lehet kényelem és hatékonyság miatt.</li>
                                    <li>Jó adherenciájú betegeknek, vagy ha a többszöri adagolás probléma.</li>
                                    <li>Stabil L-DOPA terápia mellett, wearing-off esetén.</li>
                                </ul>
                            </div>
                            <div class="bg-blue-50 p-2 rounded-lg">
                                <strong class="text-blue-700">Entacapone:</strong>
                                <ul class="list-disc list-inside ml-2 text-gray-700">
                                    <li>Bevált opció, ha a költség elsődleges szempont.</li>
                                    <li>Kombinált készítmények előnyösek lehetnek bizonyos esetekben.</li>
                                    <li>Ha a beteg jól tolerálja és az adherencia nem probléma.</li>
                                </ul>
                            </div>
                            <div class="bg-yellow-50 p-2 rounded-lg">
                                <strong class="text-yellow-700">Tolcapone:</strong>
                                <ul class="list-disc list-inside ml-2 text-gray-700">
                                    <li>Csak egyéb COMT-gátlók hatástalansága vagy intoleranciája esetén.</li>
                                    <li>Szigorú májfunkció monitorozás mellett, tapasztalt centrumban.</li>
                                </ul>
                            </div>
                        </div>
                    </div>

                     <div class="bg-white rounded-xl shadow-lg p-4 drug-card">
                        <h2 class="text-md font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-exchange-alt text-orange-500 mr-2"></i>
                            Átállítási Stratégiák
                        </h2>
                        <div class="text-xs space-y-2 text-gray-700">
                           <p><strong>Entacapone-ról Opicapone-ra:</strong> Az utolsó entacapone dózis után másnap este kezdhető az 50 mg opicapone. L-DOPA dózis általában változatlan marad kezdetben.</p>
                           <p><strong>Tolcapone-ról Opicapone-ra:</strong> Óvatos váltás javasolt, figyelembe véve a tolcapone hosszabb hatástartamát és a májmonitorozás szükségességét. Szoros orvosi felügyelet szükséges.</p>
                           <p>L-DOPA dózis módosítása dyskinesia vagy mellékhatások megjelenése esetén szükséges lehet bármelyik váltásnál.</p>
                        </div>
                    </div>
                    
                    <div class="summary-recommendation-box rounded-xl shadow-lg p-4 drug-card">
                        <h2 class="text-md font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-check-circle text-sky-600 mr-2"></i>
                            Kulcsfontosságú Ajánlások
                        </h2>
                        <ul class="list-disc list-inside text-xs text-gray-700 space-y-1">
                            <li>Az opicapone napi egyszeri adagolása jelentős előrelépést jelent a COMT-gátló terápiában.</li>
                            <li>A választást individualizálni kell a beteg klinikai profilja, adherenciája és preferenciái alapján.</li>
                            <li>A biztonságossági profil (különösen a hepatotoxicitás hiánya opicapone és entacapone esetén) fontos szempont.</li>
                            <li>Az opicapone erősebb és tartósabb OFF-idő csökkenést biztosíthat az entacaponhoz képest.</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <script>
        // Efficacy Comparison Chart for COMT Inhibitors slide
        const comtEfficacyCanvas = document.getElementById('comtEfficacyChart');
        if (comtEfficacyCanvas) {
            const comtEfficacyCtx = comtEfficacyCanvas.getContext('2d');
            new Chart(comtEfficacyCtx, {
                type: 'bar',
                data: {
                    labels: ['Opicapone 50mg', 'Entacapone 200mg*', 'Tolcapone 100mg t.i.d.'],
                    datasets: [{
                        label: 'OFF-idő csökkenés (perc/nap)',
                        data: [61, 39, 54], 
                        backgroundColor: ['#10b981', '#3b82f6', '#f59e0b'],
                        borderColor: ['#047857', '#1d4ed8', '#d97706'],
                        borderWidth: 1
                    }]
                },
                options: {
                    responsive: true, maintainAspectRatio: false, indexAxis: 'y',
                    scales: { x: { beginAtZero: true, max: 70, title: { display: false } }, y: { title: { display: false } } },
                    plugins: { legend: { display: false }, tooltip: { callbacks: { label: (c) => `${c.dataset.label}: ${c.parsed.x} perc` } } }
                }
            });
        }

        // Safety Profile Chart for COMT Inhibitors slide
        const comtSafetyCanvas = document.getElementById('comtSafetyChart');
        if (comtSafetyCanvas) {
            const comtSafetyCtx = comtSafetyCanvas.getContext('2d');
            new Chart(comtSafetyCtx, {
                type: 'radar',
                data: {
                    labels: ['Hatékonyság', 'Adagolási Kényelem', 'GI Tolerancia', 'Dyskinesia Kockázat', 'Májbiztonság'],
                    datasets: [
                        { label: 'Opicapone', data: [9, 10, 8, 7, 10], borderColor: '#10b981', backgroundColor: 'rgba(16, 185, 129, 0.2)', borderWidth: 2, pointBackgroundColor: '#10b981' },
                        { label: 'Entacapone', data: [7, 5, 7, 6, 10], borderColor: '#3b82f6', backgroundColor: 'rgba(59, 130, 246, 0.2)', borderWidth: 2, pointBackgroundColor: '#3b82f6' },
                        { label: 'Tolcapone', data: [8, 3, 5, 8, 3], borderColor: '#f59e0b', backgroundColor: 'rgba(245, 158, 11, 0.2)', borderWidth: 2, pointBackgroundColor: '#f59e0b' }
                    ]
                },
                options: {
                    responsive: true, maintainAspectRatio: false,
                    scales: { r: { beginAtZero: true, max: 10, ticks: { stepSize: 2, display: false } } },
                    plugins: { legend: { position: 'bottom', labels: { fontSize: 9, boxWidth: 10 } } }
                }
            });
        }
    </script>
</body>
</html>

<!DOCTYPE html>
<html lang="hu">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Magyarországi Implementáció és Finanszírozás</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        body { font-family: 'Inter', sans-serif; }
        .gradient-bg-slide8 {
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
        }
        .blue-accent {
            background: linear-gradient(90deg, #1e3a8a 0%, #3b82f6 100%);
        }
        .neak-box {
            background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); 
        }
        .financing-box {
            background: linear-gradient(135deg, #e0e7ff 0%, #c7d2fe 100%); 
        }
        .practical-box {
            background: linear-gradient(135deg, #ecfdf5 0%, #d1fae5 100%); 
        }
        .admin-box {
            background: linear-gradient(135deg, #fffbeb 0%, #fef3c7 100%); 
        }
        .cost-box {
            background: linear-gradient(135deg, #fce7f3 0%, #fbcfe8 100%); 
        }
        .process-step {
            background: white;
            border-radius: 8px;
            position: relative;
            padding: 0.75rem; 
            margin-bottom: 1rem; 
            box-shadow: 0 2px 4px rgba(0,0,0,0.05);
        }
        .process-arrow {
            text-align: center;
            color: #3b82f6; 
            font-size: 1.5rem; 
            line-height: 1;
            margin-bottom: 0.5rem; 
        }
        .process-step:last-child .process-arrow {
            display: none;
        }

        .highlight-box {
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.05);
            transition: transform 0.2s ease, box-shadow 0.2s ease;
            border-width: 1px;
            border-color: #e5e7eb; 
        }
        .highlight-box:hover {
            transform: translateY(-2px);
            box-shadow: 0 6px 12px rgba(0, 0, 0, 0.1);
        }
        .info-item {
            padding: 0.5rem;
            background-color: rgba(255,255,255,0.7);
            border-radius: 0.375rem; 
            margin-bottom: 0.5rem;
        }
        .info-item strong {
            color: #1e3a8a; 
        }
    </style>
</head>
<body class="m-0 p-0">
    <div class="w-full gradient-bg-slide8" style="width: 1280px; min-height: 720px;">
        <div class="blue-accent h-16 flex items-center px-8 text-white">
            <div class="flex items-center space-x-3">
                <i class="fas fa-map-marked-alt text-2xl"></i>
                <h1 class="text-2xl font-bold">Magyarországi Implementáció és Finanszírozás</h1>
            </div>
            <div class="ml-auto flex items-center space-x-3">
                <img src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMzIiIGhlaWdodD0iMjEiIHZpZXdCb3g9IjAgMCAzMiAyMSIgZmlsbD0ibm9uZSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj4KPHJlY3Qgd2lkdGg9IjMyIiBoZWlnaHQ9IjciIGZpbGw9IiNDRDJCNzAiLz4KPHJlY3QgeT0iNyIgd2lkdGg9IjMyIiBoZWlnaHQ9IjciIGZpbGw9IndoaXRlIi8+CjxyZWN0IHk9IjE0IiB3aWR0aD0iMzIiIGhlaWdodD0iNyIgZmlsbD0iIzQ3NzE0QiIvPgo8L3N2Zz4K" alt="Magyar zászló" class="w-8 h-auto rounded-sm">
                <span class="text-xs font-medium uppercase">NEAK • Neurológiai Szakellátás</span>
            </div>
        </div>

        <div class="px-6 py-4">
            <div class="grid grid-cols-3 gap-4">
                <div class="space-y-3">
                    <div class="neak-box rounded-xl p-4 highlight-box">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-landmark text-blue-600 mr-2"></i> NEAK Engedélyezés és Támogatás
                        </h2>
                        <div class="space-y-2 text-xs">
                            <div class="info-item"><strong>Indikáció:</strong> Felnőttkori Parkinson-kór, L-DOPA/DDCI mellett adjuvánsként, end-of-dose motoros fluktuációk esetén, ha ezen kombinációkkal nem stabilizálható.</div>
                            <div class="info-item"><strong>ATC kód:</strong> N04BX04</div>
                            <div class="info-item"><strong>Támogatási kategória:</strong> Általában "EÜ70%" (70%-os támogatás) vagy "EÜ90%" (kiemelt indikációban 90%-os támogatás). Egyedi méltányosság alapján 100% is elérhető.</div>
                             <div class="info-item"><strong>Felírási jogosultság:</strong> Neurológus szakorvos, kijelölt Parkinson centrumokban.</div>
                        </div>
                    </div>

                    <div class="admin-box rounded-xl p-4 highlight-box">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-user-check text-yellow-600 mr-2"></i> Jogosultsági Kritáriumok (általános)
                        </h2>
                        <ul class="list-disc list-inside text-xs text-gray-700 space-y-1 pl-2">
                            <li>Igazolt Parkinson-kór (ált. min. 1-3 éves diagnózis).</li>
                            <li>Stabil L-DOPA/DDCI terápia (ált. min. 1 év).</li>
                            <li>Dokumentált "end-of-dose" motoros fluktuációk.</li>
                            <li>Betegnaplóval alátámasztott OFF periódusok.</li>
                            <li>Másodlagos COMT-gátló (entacapone) elégtelen hatása vagy intoleranciája esetén prioritás.</li>
                            <li>Hoehn-Yahr stádium (általában I-IV ON állapotban).</li>
                        </ul>
                    </div>
                     <div class="practical-box rounded-xl p-4 highlight-box">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-hospital-user text-green-600 mr-2"></i> Szakellátó Centrumok és Felírás
                        </h2>
                        <div class="text-xs text-gray-700 space-y-1">
                            <p>Az opicapone felírása jellemzően neurológiai szakorvosokhoz kötött, akik Parkinson-kór kezelésében jártasak.</p>
                            <ul class="list-disc list-inside pl-2 mt-1">
                                <li>Egyetemi Neurológiai Klinikák</li>
                                <li>Országos Mentális, Ideggyógyászati és Idegsebészeti Intézet (OMIII)</li>
                                <li>Megyei és városi kórházak neurológiai osztályai, szakambulanciái</li>
                                <li>Kijelölt Parkinson vagy Mozgászavar Centrumok</li>
                            </ul>
                             <p class="mt-1">A pontos felírási protokoll és a centrumok listája a NEAK aktuális közleményeiben és a szakmai irányelvekben található.</p>
                        </div>
                    </div>
                </div>

                <div class="space-y-3">
                    <div class="financing-box rounded-xl p-4 highlight-box">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-project-diagram text-indigo-600 mr-2"></i> Finanszírozási Folyamat (Egyszerűsítve)
                        </h2>
                        <div class="space-y-1 text-xs">
                            <div class="process-step">
                                <div class="flex items-center space-x-2">
                                    <div class="bg-indigo-500 text-white rounded-full w-6 h-6 flex items-center justify-center font-bold">1</div>
                                    <div><strong>Neurológiai Vizsgálat:</strong> Indikáció megállapítása, beteg alkalmasságának felmérése.</div>
                                </div>
                                <div class="process-arrow"><i class="fas fa-arrow-down"></i></div>
                            </div>
                            <div class="process-step">
                                <div class="flex items-center space-x-2">
                                    <div class="bg-indigo-500 text-white rounded-full w-6 h-6 flex items-center justify-center font-bold">2</div>
                                    <div><strong>Dokumentáció:</strong> Anamnézis, betegnapló, korábbi kezelések, UPDRS, stb. összegyűjtése.</div>
                                </div>
                                <div class="process-arrow"><i class="fas fa-arrow-down"></i></div>
                            </div>
                            <div class="process-step">
                                <div class="flex items-center space-x-2">
                                    <div class="bg-indigo-500 text-white rounded-full w-6 h-6 flex items-center justify-center font-bold">3</div>
                                    <div><strong>NEAK Kérelem (ha szükséges):</strong> Szakorvosi javaslat, vény felírása. Egyedi méltányossági kérelem benyújtása, ha a standard támogatás nem fedezi.</div>
                                </div>
                                <div class="process-arrow"><i class="fas fa-arrow-down"></i></div>
                            </div>
                            <div class="process-step">
                                <div class="flex items-center space-x-2">
                                    <div class="bg-green-500 text-white rounded-full w-6 h-6 flex items-center justify-center font-bold">4</div>
                                    <div><strong>Jóváhagyás és Gyógyszerkiváltás:</strong> Pozitív elbírálás esetén a gyógyszer kiváltható a patikában a támogatott áron.</div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="bg-white rounded-xl shadow-lg p-4 highlight-box">
                        <h2 class="text-md font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-file-invoice-dollar text-purple-600 mr-2"></i> Költségek és Térítési Arányok
                        </h2>
                        <div style="height: 120px;"><canvas id="reimbursementChart"></canvas></div>
                        <div class="text-xs text-gray-600 mt-2">
                            <p>A gyógyszer teljes ára kb. 35,000 - 45,000 Ft/hó (28x50mg). A beteg által fizetendő összeg a támogatás mértékétől függ:</p>
                            <ul class="list-disc list-inside pl-2 mt-1">
                                <li><strong>70% támogatás:</strong> Beteg fizet ~10,500 - 13,500 Ft</li>
                                <li><strong>90% támogatás:</strong> Beteg fizet ~3,500 - 4,500 Ft</li>
                                <li><strong>Egyedi méltányosság (100%):</strong> Beteg fizet 0 Ft + dobozdíj</li>
                            </ul>
                            <p class="mt-1"><em>(A pontos összegek változhatnak, tájékoztató jellegű adatok.)</em></p>
                        </div>
                    </div>
                </div>

                <div class="space-y-3">
                     <div class="cost-box rounded-xl p-4 highlight-box">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-tasks text-pink-600 mr-2"></i> Adminisztratív Teendők és Dokumentáció
                        </h2>
                        <ul class="list-disc list-inside text-xs text-gray-700 space-y-1 pl-2">
                            <li>Részletes neurológiai szakorvosi javaslat.</li>
                            <li>Betegnapló (általában 1-2 hétre visszamenőleg).</li>
                            <li>Korábbi antiparkinsonos kezelések és azok hatásosságának dokumentálása.</li>
                            <li>UPDRS III (motoros) és IV (komplikációk) pontszámok rögzítése.</li>
                            <li>Amennyiben releváns, egyéb képalkotó vagy laboratóriumi leletek.</li>
                            <li>Egyedi méltányossági kérelem esetén részletes indoklás, szociális helyzet leírása.</li>
                            <li>Rendszeres felülvizsgálat (ált. 3-6 havonta) a terápia folytatásához.</li>
                        </ul>
                    </div>
                    <div class="neak-box rounded-xl p-4 highlight-box">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-info-circle text-blue-600 mr-2"></i> Információ és Kapcsolatok
                        </h2>
                        <div class="space-y-2 text-xs">
                            <div class="info-item"><strong>NEAK (Nemzeti Egészségbiztosítási Alapkezelő):</strong><br> Web: <a href="https://neak.gov.hu" target="_blank" class="text-blue-500 hover:underline">neak.gov.hu</a>, Telefon: +36-1-350-2001</div>
                            <div class="info-item"><strong>Magyar Neurológiai Társaság:</strong><br> Web: <a href="https://www.neurotars.hu" target="_blank" class="text-blue-500 hover:underline">neurotars.hu</a> (szakmai irányelvek, centrumok)</div>
                            <div class="info-item"><strong>Parkinson Betegek Egyesületei:</strong> Tájékoztatás, betegtámogatás. (pl. Magyar Parkinson Társaság)</div>
                            <div class="info-item"><strong>Gyártó (BIAL) képviselete:</strong> Szakmai információk, betegtájékoztató anyagok.</div>
                        </div>
                    </div>
                     <div class="admin-box rounded-xl p-4 highlight-box">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-calendar-alt text-yellow-600 mr-2"></i> Várható Időtartamok
                        </h2>
                        <ul class="list-disc list-inside text-xs text-gray-700 space-y-1 pl-2">
                            <li><strong>Dokumentáció és kérelem előkészítése:</strong> 1-2 hét</li>
                            <li><strong>NEAK elbírálás (egyedi méltányosság):</strong> 30-90 nap</li>
                            <li><strong>Standard támogatású vény érvényesítése:</strong> Azonnali</li>
                            <li><strong>Terápiás hatás értékelése:</strong> 2-4 hét után kezdődően</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <script>
        // Reimbursement Rates Chart for Magyarorszagi slide
        const reimbursementMagyarorszagiCanvas = document.getElementById('reimbursementChart');
        if (reimbursementMagyarorszagiCanvas) { 
            const reimbursementMagyarorszagiCtx = reimbursementMagyarorszagiCanvas.getContext('2d');
            new Chart(reimbursementMagyarorszagiCtx, {
                type: 'bar',
                data: {
                    labels: ['70% NEAK Tám.', '90% NEAK Tám.', '100% Egyedi Mélt.'],
                    datasets: [{
                        label: 'Beteg által fizetendő (becsült %)',
                        data: [30, 10, 0.5], 
                        backgroundColor: ['#60a5fa', '#3b82f6', '#1d4ed8'],
                        borderColor: ['#3b82f6', '#1d4ed8', '#1e3a8a'],
                        borderWidth: 1
                    }]
                },
                options: {
                    responsive: true, maintainAspectRatio: false, indexAxis: 'y',
                    scales: { x: { beginAtZero: true, max: 35, title: { display: false, text: 'Költség %' } }, y: { title: { display: false } } },
                    plugins: { legend: { display: false }, tooltip: { callbacks: { label: (c) => `Beteg fizet: ~${c.parsed.x}%` } } }
                }
            });
        }
    </script>
</body>
</html>

<!DOCTYPE html>
<html lang="hu">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Következtetések és Klinikai Ajánlások</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        body { font-family: 'Inter', sans-serif; }
        .gradient-bg-slide9 {
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
        }
        .blue-accent {
            background: linear-gradient(90deg, #1e3a8a 0%, #3b82f6 100%);
        }
        .evidence-box {
            background: linear-gradient(135deg, #f0fdf4 0%, #dcfce7 100%); 
        }
        .recommendations-box {
            background: linear-gradient(135deg, #eef2ff 0%, #e0e7ff 100%); 
        }
        .takeaway-box {
            background: linear-gradient(135deg, #f5f3ff 0%, #ede9fe 100%); 
        }
        .highlight-card {
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.05);
            transition: all 0.2s ease-in-out;
            border-width: 1px;
            border-color: #e5e7eb;
        }
        .highlight-card:hover {
            transform: translateY(-2px);
            box-shadow: 0 7px 14px rgba(0, 0, 0, 0.07);
        }
        .evidence-level {
            display: inline-block;
            padding: 2px 8px;
            border-radius: 9999px; 
            font-size: 0.65rem; 
            font-weight: 600; 
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }
        .level-a { background-color: #10b981; color: white; } 
        .level-b { background-color: #3b82f6; color: white; } 
        
        .algorithm-step {
            position: relative;
            padding: 0.625rem; 
            margin-bottom: 0.75rem; 
            background-color: rgba(255,255,255,0.8);
            border-left-width: 4px;
            border-radius: 0.375rem; 
        }
        .algorithm-step .step-icon {
            background-color: #3b82f6; 
            color: white;
            border-radius: 50%;
            width: 24px; height: 24px;
            display: flex; align-items: center; justify-content: center;
            font-size: 0.75rem; font-weight: bold;
            flex-shrink: 0;
        }
        .algorithm-arrow {
            text-align: center;
            color: #60a5fa; 
            font-size: 1.25rem; 
            line-height: 0.5;
            margin-bottom: 0.5rem; 
        }
        .algorithm-step:last-child .algorithm-arrow {
            display: none;
        }
        .takeaway-item {
             background-color: rgba(255,255,255,0.7);
             padding: 0.75rem;
             border-radius: 0.375rem;
             border-left-width: 3px;
        }
        .recommendation-grade {
            padding: 0.125rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: bold;
            color: white;
        }

        /* Styles for the reference box, integrated here */
        .reference-box-container { /* Added a container for centering/positioning */
            display: flex;
            justify-content: center;
            padding: 2rem 0; /* Add some padding around the box */
        }
        .reference-box {
            background-color: #ffffff;
            border: 1px solid #e2e8f0;
            border-radius: 0.75rem; 
            box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -1px rgba(0, 0, 0, 0.06);
            max-width: 800px; 
            width: 100%;
            margin: 1rem auto; /* Center the box if it's narrower than the slide */
        }
        .reference-header {
            background-color: #1e3a8a; 
            color: white;
            padding: 0.75rem 1.25rem; 
            border-top-left-radius: 0.75rem;
            border-top-right-radius: 0.75rem;
            cursor: pointer;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }
        .reference-header h3 {
            font-size: 1.125rem; 
            font-weight: 600;
        }
        .reference-content {
            padding: 1.25rem; 
            max-height: 400px; 
            overflow-y: auto;
            border-top: 1px solid #e2e8f0;
        }
        .reference-item {
            padding: 0.75rem 0;
            border-bottom: 1px solid #f1f5f9; 
        }
        .reference-item:last-child {
            border-bottom: none;
        }
        .reference-item .title {
            font-weight: 600;
            color: #1e293b; 
            margin-bottom: 0.25rem;
        }
        .reference-item .authors {
            font-size: 0.875rem; 
            color: #475569; 
            margin-bottom: 0.25rem;
        }
        .reference-item .journal {
            font-size: 0.875rem;
            color: #64748b; 
            font-style: italic;
        }
        .reference-item .year-doi {
            font-size: 0.75rem; 
            color: #94a3b8; 
            margin-top: 0.25rem;
        }
        .reference-item .doi-link {
            color: #3b82f6; 
            text-decoration: none;
        }
        .reference-item .doi-link:hover {
            text-decoration: underline;
        }
        .toggle-icon {
            transition: transform 0.3s ease;
        }
        .reference-content.hidden + .reference-header .toggle-icon {
            transform: rotate(-90deg);
        }
    </style>
</head>
<body class="m-0 p-0">
    <div class="w-full gradient-bg-slide9" style="width: 1280px; min-height: 720px;">
        <div class="blue-accent h-16 flex items-center px-8 text-white">
            <div class="flex items-center space-x-3">
                <i class="fas fa-award text-2xl"></i>
                <h1 class="text-2xl font-bold">Következtetések és Klinikai Ajánlások</h1>
            </div>
            <div class="ml-auto bg-white bg-opacity-10 rounded-lg px-3 py-1">
                <span class="text-xs font-medium uppercase">Evidence-Based Neurológiai Gyakorlat</span>
            </div>
        </div>

        <div class="px-6 py-4">
            <div class="grid grid-cols-3 gap-4">
                <div class="space-y-3">
                    <div class="evidence-box rounded-xl p-4 highlight-card">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-book-medical text-green-600 mr-2"></i> Kulcs Evidenciák Összegzése
                        </h2>
                        <div class="space-y-2 text-xs">
                            <div class="bg-white p-2 rounded-md shadow-sm">
                                <div class="flex justify-between items-center mb-1">
                                    <strong class="text-green-700">BIPARK I & II Vizsgálatok</strong>
                                    <span class="evidence-level level-a">Szint: A</span>
                                </div>
                                <ul class="list-disc list-inside text-gray-700 pl-2">
                                    <li>Szignifikáns OFF-idő csökkenés (~60 perc vs. placebo).</li>
                                    <li>Opicapone 50 mg non-inferior vagy jobb, mint az entacapone.</li>
                                </ul>
                            </div>
                            <div class="bg-white p-2 rounded-md shadow-sm">
                                <div class="flex justify-between items-center mb-1">
                                    <strong class="text-green-700">OPTIPARK & Hosszú távú vizsgálatok</strong>
                                    <span class="evidence-level level-b">Szint: B</span>
                                </div>
                                <ul class="list-disc list-inside text-gray-700 pl-2">
                                    <li>Tartós hatékonyság (≥1 év) és jó tolerálhatóság.</li>
                                    <li>Valós klinikai gyakorlatban is igazolt előnyök.</li>
                                </ul>
                            </div>
                            <div class="bg-white p-2 rounded-md shadow-sm">
                                <div class="flex justify-between items-center mb-1">
                                    <strong class="text-green-700">Biztonságossági Profil</strong>
                                    <span class="evidence-level level-a">Szint: A</span>
                                </div>
                                <ul class="list-disc list-inside text-gray-700 pl-2">
                                    <li>Nincs klinikailag releváns hepatotoxicitás.</li>
                                    <li>Leggyakoribb mellékhatás a dyskinesia (L-DOPA hatás miatt).</li>
                                    <li>Alacsonyabb GI mellékhatás-ráta az entacaponhoz képest.</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                     <div class="bg-white rounded-xl shadow-lg p-4 highlight-card">
                        <h2 class="text-md font-bold text-gray-800 mb-2 flex items-center">
                            <i class="fas fa-chart-pie text-purple-600 mr-2"></i> Opicapone Előnyprofilja
                        </h2>
                        <div style="height: 130px;"><canvas id="benefitChart"></canvas></div>
                        <p class="text-xs text-gray-500 mt-1 text-center">Kulcsfontosságú előnyök értékelése</p>
                    </div>
                     <div class="recommendations-box rounded-xl p-4 highlight-card">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-users-cog text-indigo-600 mr-2"></i> Ideális Betegprofil
                        </h2>
                        <ul class="list-disc list-inside text-xs text-gray-700 space-y-1 pl-2">
                            <li>L-DOPA kezelt Parkinson-kóros betegek motoros fluktuációkkal (wearing-off).</li>
                            <li>Akiknél a napi egyszeri adagolás javíthatja az adherenciát.</li>
                            <li>Akiknél az entacapone nem volt elég hatékony vagy tolerálható.</li>
                            <li>Korai és középsúlyos stádiumban, ahol a fluktuációk még nem extrémek.</li>
                            <li>Nincs súlyos májbetegségük.</li>
                        </ul>
                    </div>
                </div>

                <div class="space-y-3">
                    <div class="recommendations-box rounded-xl p-4 highlight-card">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-directions text-indigo-600 mr-2"></i> Klinikai Döntési Algoritmus (Javaslat)
                        </h2>
                        <div class="space-y-1 text-xs">
                            <div class="algorithm-step border-green-500">
                                <div class="flex items-start space-x-2">
                                    <div class="step-icon">1</div>
                                    <div><strong>Fluktuáció Felismerése:</strong> Betegnapló, célzott kérdések az OFF-periódusokról.</div>
                                </div>
                                <div class="algorithm-arrow"><i class="fas fa-chevron-down"></i></div>
                            </div>
                            <div class="algorithm-step border-blue-500">
                                <div class="flex items-start space-x-2">
                                    <div class="step-icon">2</div>
                                    <div><strong>L-DOPA Optimalizálás:</strong> Dózisok elosztása, CR formulák, szükség esetén dózisemelés.</div>
                                </div>
                                <div class="algorithm-arrow"><i class="fas fa-chevron-down"></i></div>
                            </div>
                            <div class="algorithm-step border-purple-500">
                                <div class="flex items-start space-x-2">
                                    <div class="step-icon">3</div>
                                    <div><strong>COMT-gátló Bevezetése:</strong> <strong class="text-purple-700">Opicapone 50 mg</strong> (este) javasolt elsőként a kényelem és hatékonyság miatt. Alternatíva: entacapone.</div>
                                </div>
                                 <div class="algorithm-arrow"><i class="fas fa-chevron-down"></i></div>
                            </div>
                            <div class="algorithm-step border-yellow-600">
                                <div class="flex items-start space-x-2">
                                    <div class="step-icon">4</div>
                                    <div><strong>Hatás Értékelése (4-8 hét):</strong> OFF-idő, ON-idő minősége, dyskinesiák. Szükség esetén L-DOPA dózis módosítása.</div>
                                </div>
                                <div class="algorithm-arrow"><i class="fas fa-chevron-down"></i></div>
                            </div>
                             <div class="algorithm-step border-red-500">
                                <div class="flex items-start space-x-2">
                                    <div class="step-icon">5</div>
                                    <div><strong>További Lehetőségek:</strong> MAO-B gátlók, dopamin agonisták, amantadin, szükség esetén DBS vagy pumpa terápia mérlegelése.</div>
                                </div>
                            </div>
                        </div>
                    </div>
                     <div class="evidence-box rounded-xl p-4 highlight-card">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-clipboard-check text-green-600 mr-2"></i> Graduált Klinikai Ajánlások
                        </h2>
                        <div class="space-y-2 text-xs">
                            <div class="bg-white p-2 rounded-md shadow-sm">
                                <div class="flex items-center space-x-2 mb-1">
                                    <span class="recommendation-grade bg-green-500">I.A</span>
                                    <strong class="text-green-700">Erősen ajánlott:</strong>
                                </div>
                                <p class="text-gray-700">Opicapone 50 mg naponta egyszer adjuvánsként L-DOPA/DDCI-hez Parkinson-kóros betegeknél end-of-dose motoros fluktuációk csökkentésére.</p>
                            </div>
                            <div class="bg-white p-2 rounded-md shadow-sm">
                                <div class="flex items-center space-x-2 mb-1">
                                    <span class="recommendation-grade bg-blue-500">II.a B</span>
                                    <strong class="text-blue-700">Mérlegelendő:</strong>
                                </div>
                                <p class="text-gray-700">Opicapone választása entacapone helyett a jobb adherencia és potenciálisan jobb hatékonyság/tolerálhatóság érdekében.</p>
                            </div>
                            <div class="bg-white p-2 rounded-md shadow-sm">
                                <div class="flex items-center space-x-2 mb-1">
                                    <span class="recommendation-grade bg-yellow-600">II.b C</span>
                                    <strong class="text-yellow-700">Fontolóra vehető:</strong>
                                </div>
                                <p class="text-gray-700">L-DOPA dózisának csökkentése dyskinesia megjelenésekor opicapone terápia mellett.</p>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="space-y-3">
                    <div class="takeaway-box rounded-xl p-4 highlight-card">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-bullhorn text-violet-600 mr-2"></i> Kulcs Üzenetek (Take-Home)
                        </h2>
                        <div class="space-y-2 text-xs">
                            <div class="takeaway-item border-violet-500">
                                <i class="fas fa-check-circle text-violet-500 mr-1"></i> <strong>Hatékony:</strong> Jelentősen csökkenti az OFF-időt és javítja az ON-idő minőségét.
                            </div>
                            <div class="takeaway-item border-violet-500">
                                <i class="fas fa-shield-alt text-violet-500 mr-1"></i> <strong>Biztonságos:</strong> Jól tolerálható, nincs szükség májfunkció-monitorozásra.
                            </div>
                            <div class="takeaway-item border-violet-500">
                                <i class="fas fa-user-clock text-violet-500 mr-1"></i> <strong>Kényelmes:</strong> Napi egyszeri adagolás javítja az adherenciát.
                            </div>
                            <div class="takeaway-item border-violet-500">
                                <i class="fas fa-balance-scale text-violet-500 mr-1"></i> <strong>Versenyképes:</strong> Potens alternatíva más COMT-gátlókkal szemben.
                            </div>
                             <div class="takeaway-item border-violet-500">
                                <i class="fas fa-puzzle-piece text-violet-500 mr-1"></i> <strong>Integrálható:</strong> Jól beilleszthető a Parkinson-kór komplex kezelési stratégiájába.
                            </div>
                        </div>
                    </div>
                     <div class="bg-white rounded-xl shadow-lg p-4 highlight-card">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-tasks text-blue-600 mr-2"></i> Implementációs Emlékeztető
                        </h2>
                        <ul class="list-disc list-inside text-xs text-gray-700 space-y-1 pl-2">
                            <li><strong>Azonosítsa</strong> a motoros fluktuációval küzdő betegeket.</li>
                            <li><strong>Optimalizálja</strong> az alap L-DOPA terápiát.</li>
                            <li><strong>Fontolja meg</strong> az opicapone-t mint hatékony és kényelmes COMT-gátlót.</li>
                            <li><strong>Monitorozza</strong> a hatást és a lehetséges dyskinesiákat.</li>
                            <li><strong>Edukálja</strong> a beteget a helyes gyógyszerszedésről (esti bevétel).</li>
                        </ul>
                    </div>
                    <div class="recommendations-box rounded-xl p-4 highlight-card">
                        <h2 class="text-md font-bold text-gray-800 mb-3 flex items-center">
                            <i class="fas fa-flask text-indigo-600 mr-2"></i> Jövőbeli Perspektívák
                        </h2>
                        <ul class="list-disc list-inside text-xs text-gray-700 space-y-1 pl-2">
                            <li>További real-world adatok gyűjtése a hosszú távú hatásokról és speciális populációkban.</li>
                            <li>Az opicapone szerepének vizsgálata a Parkinson-kór korábbi fázisaiban.</li>
                            <li>Kombinációs stratégiák finomítása más antiparkinsonos szerekkel.</li>
                            <li>Non-motoros tünetekre gyakorolt hatásának feltárása.</li>
                            <li>Farmakogenomikai vizsgálatok a terápiás válasz predikciójára.</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <div class="reference-box-container">
        <div class="reference-box">
            <div class="reference-header" id="referenceToggle">
                <h3>Irodalomjegyzék (References)</h3>
                <i class="fas fa-chevron-down toggle-icon"></i>
            </div>
            <div class="reference-content hidden" id="referenceContent">
                <p id="loadingMessage" class="text-gray-500">Betöltés...</p>
            </div>
        </div>
    </div>

    <script>
        // Benefit Chart for Kovetkeztetesek slide
        const benefitKovetkeztetesekCanvas = document.getElementById('benefitChart');
        if (benefitKovetkeztetesekCanvas) { 
            const benefitKovetkeztetesekCtx = benefitKovetkeztetesekCanvas.getContext('2d');
            new Chart(benefitKovetkeztetesekCtx, {
                type: 'radar',
                data: {
                    labels: ['OFF-idő ↓', 'Adherencia ↑', 'Tolerálhatóság', 'Hatáserősség', 'Májbiztonság'],
                    datasets: [{
                        label: 'Opicapone Előnyprofil',
                        data: [9, 10, 8, 9, 10], 
                        borderColor: '#8b5cf6', 
                        backgroundColor: 'rgba(139, 92, 246, 0.2)',
                        borderWidth: 2,
                        pointBackgroundColor: '#8b5cf6'
                    }]
                },
                options: {
                    responsive: true, maintainAspectRatio: false,
                    scales: { r: { beginAtZero: true, max: 10, ticks: { stepSize: 2, display: false } } },
                    plugins: { legend: { display: false } }
                }
            });
        }

        // --- Reference Box JavaScript ---
        const csvDataString = `DOI,PMID,arXiv ID,Title,Abstract,Authors,Journal,Year
10.3390/brainsci8010004,29295486,,Adaptive Deep Brain Stimulation (aDBS) for Tourette Syndrome,"Deep brain stimulation (DBS) has emerged as a novel therapy for the treatment of several movement and neuropsychiatric disorders, and may also be suitable for the treatment of Tourette syndrome (TS). The main DBS targets used to date in patients with TS are located within the basal ganglia-thalamo-cortical circuit involved in the pathophysiology of this syndrome. They include the ventralis oralis/centromedian-parafascicular (Vo/CM-Pf) nucleus of the thalamus and the nucleus accumbens. Current DBS treatments deliver continuous electrical stimulation and are not designed to adapt to the patient’s symptoms, thereby contributing to unwanted side effects. Moreover, continuous DBS can lead to rapid battery depletion, which necessitates frequent battery replacement surgeries. Adaptive deep brain stimulation (aDBS), which is controlled based on neurophysiological biomarkers, is considered one of the most promising approaches to optimize clinical benefits and to limit the side effects of DBS. aDBS consists of a closed-loop system designed to measure and analyse a control variable reflecting the patient’s clinical condition and to modify on-line stimulation settings to improve treatment efficacy. Local field potentials (LFPs), which are sums of pre- and post-synaptic activity arising from large neuronal populations, directly recorded from electrodes implanted for DBS can theoretically represent a reliable correlate of clinical status in patients with TS. The well-established LFP-clinical correlations in patients with Parkinson’s disease reported in the last few years provide the rationale for developing and implementing new aDBS devices whose efficacies are under evaluation in humans. Only a few studies have investigated LFP activity recorded from DBS target structures and the relationship of this activity to clinical symptoms in TS. Here, we review the available literature supporting the feasibility of an LFP-based aDBS approach in patients with TS. In addition, to increase such knowledge, we report explorative findings regarding LFP data recently acquired and analysed in patients with TS after DBS electrode implantation at rest, during voluntary and involuntary movements (tics), and during ongoing DBS. Data available up to now suggest that patients with TS have oscillatory patterns specifically associated with the part of the brain they are recorded from, and thereby with clinical manifestations. The Vo/CM-Pf nucleus of the thalamus is involved in movement execution and the pathophysiology of TS. Moreover, the oscillatory patterns in TS are specifically modulated by DBS treatment, as reflected by improvements in TS symptoms. These findings suggest that LFPs recorded from DBS targets may be used to control new aDBS devices capable of adaptive stimulation responsive to the symptoms of TS.","Sara Marceglia,Sara Marceglia,Sara Marceglia,Manuela Rosa,Manuela Rosa,Domenico Servello,Domenico Servello,Mauro Porta,Mauro Porta,S. Barbieri,Sergio Barbieri,Elena Moro,Elena Moro,Elena Moro,Elena Moro,Alberto Priori,Alberto Priori",Brain Sciences,2017
10.1212/wnl.0000000000204762,,,Chronic Adaptive DBS Provides Similar “On” Time with Trend of Improvement Compared to Continuous DBS in Parkinson’s Disease and 98% of Participants Chose to Remain on aDBS (S2.008),,"Helen Bronte-Stewart,Beudel Martijn,Jill L Ostrem,Simon Little,Leonardo Almeida,Adolfo Ramirez Zamora,Alfonso Fasano,Travis J Hassell,Kyle Mitchell,Elena Moro,M. Gostkowski,N. Sarangmat,Scott Stanslaski,L. Tonder,Ye Tan,Tim Goble,Rebekah Summers,R. Raike,Todd M. Herrington",Neurology,2024
10.1101/2024.06.26.24309418,38978669,,Beta Burst-Driven Adaptive Deep Brain Stimulation Improves Gait Impairment and Freezing of Gait in Parkinson’s Disease,"Background: Freezing of gait (FOG) is a debilitating symptom of Parkinson's disease (PD) that is often refractory to medication. Pathological prolonged beta bursts within the subthalamic nucleus (STN) are associated with both worse impairment and freezing behavior in PD, which are improved with deep brain stimulation (DBS). The goal of the current study was to investigate the feasibility, safety, and tolerability of beta burst-driven adaptive DBS (aDBS) for FOG in PD. Methods: Seven individuals with PD were implanted with the investigational Summit RC+S DBS system (Medtronic, PLC) with leads placed bilaterally in the STN. A PC-in-the-loop architecture was used to adjust stimulation amplitude in real-time based on the observed beta burst durations in the STN. Participants performed either a harnessed stepping-in-place task or a free walking turning and barrier course, as well as clinical motor assessments and instrumented measures of bradykinesia, OFF stimulation, on aDBS, continuous DBS (cDBS), or random intermittent DBS (iDBS). Results: Beta burst driven aDBS was successfully implemented and deemed safe and tolerable in all seven participants. Gait metrics such as overall percent time freezing and mean peak shank angular velocity improved from OFF to aDBS and showed similar efficacy as cDBS. Similar improvements were also seen for overall clinical motor impairment, including tremor, as well as quantitative metrics of bradykinesia. Conclusion: Beta burst driven adaptive DBS was feasible, safe, and tolerable in individuals with PD with gait impairment and FOG.","K. B. Wilkins,M. Petrucci,E. Lambert,J. Melbourne,A. Gala,P. Akella,L. Parisi,C. Cui,Y. Kehnemouyi,S. Hoffman,S. Aditham,C. Diep,H.J. Dorris,J. E. Parker,J. Herron,H. Bronte-Stewart",medRxiv,2024
10.1101/2024.08.14.24312002,,,Movement-responsive deep brain stimulation for Parkinson's Disease using a remotely optimized neural decoder,"Deep brain stimulation (DBS) has garnered widespread use as an effective treatment for advanced Parkinson's Disease (PD). Conventional DBS (cDBS) provides electrical stimulation to the basal ganglia at fixed amplitude and frequency, yet patients' therapeutic needs are often dynamic with residual symptom fluctuations or side-effects. Adaptive DBS (aDBS) is an emerging technology that modulates stimulation with respect to real-time clinical, physiological, or behavioral states, enabling therapy to dynamically align with patient-specific symptoms. Here, we report a novel aDBS algorithm intended to mitigate movement slowness by delivering targeted stimulation increases during movement using decoded motor signals from the brain. Compared to cDBS and a control algorithm that decreases stimulation during movement, our approach demonstrates enhanced clinical efficacy, with improvements in movement speed, reduced dyskinesia, and better patient-reported therapeutic quality. Furthermore, we demonstrate proof-of-principle of a machine learning pipeline capable of remotely optimizing aDBS parameters in a home setting. This work illustrates the potential of movement-responsive aDBS as a new therapeutic approach and highlights how machine learning assisted programming can simplify optimization to facilitate translational scalability.","T. C. Dixon,G. Strandquist,A. Zeng,T. Fraczek,R. Bechtold,D. Lawrence,S. Ravi,P. Starr,J. Gallant,J. Herron,S. Little",medRxiv,2024
10.3390/bioengineering11100990,39451366,,Adaptive vs. Conventional Deep Brain Stimulation: One-Year Subthalamic Recordings and Clinical Monitoring in a Patient with Parkinson’s Disease,"Conventional DBS (cDBS) for Parkinson’s disease uses constant, predefined stimulation parameters, while the currently available adaptive DBS (aDBS) provides the possibility of adjusting current amplitude with respect to subthalamic activity in the beta band (13–30 Hz). This preliminary study on one patient aims to describe how these two stimulation modes affect basal ganglia dynamics and, thus, behavior in the long term. We collected clinical data (UPDRS-III and -IV) and subthalamic recordings of one patient with Parkinson’s disease treated for one year with aDBS, alternated with short intervals of cDBS. Moreover, after nine months, the patient discontinued all dopaminergic drugs while keeping aDBS. Clinical benefits of aDBS were superior to those of cDBS, both with and without medications. This improvement was paralleled by larger daily fluctuations of subthalamic beta activity. Moreover, with aDBS, subthalamic beta activity decreased during asleep with respect to awake hours, while it remained stable in cDBS. These preliminary data suggest that aDBS might be more effective than cDBS in preserving the functional role of daily beta fluctuations, thus leading to superior clinical benefit. Our results open new perspectives for a restorative brain network effect of aDBS as a more physiological, bidirectional, brain–computer interface.","L. Caffi,L. Romito,C. Palmisano,V. Aloia,M. Arlotti,L. Rossi,S. Marceglia,A. Priori,R. Eleopra,V. Levi,A. Mazzoni,I. Isaias",Bioengineering,2024
10.1038/s41531-025-00974-5,40325017,,Will adaptive deep brain stimulation for Parkinson’s disease become a real option soon? A Delphi consensus study,"While conventional deep brain stimulation (cDBS) treatment delivers continuous electrical stimuli, new adaptive DBS (aDBS) technology provides dynamic symptom-related stimulation. Research data are promising, and devices are already available, but are we ready for it? We asked leading DBS experts worldwide (n = 21) to discuss a research agenda for aDBS research in the near future to allow full adoption. A 5-point Likert scale questionnaire, along with a Delphi method, was employed. In the next 10 years, aDBS will be clinical routine, but research is needed to define which patients would benefit more from the treatment; second, implantation and programming procedures should be simplified to allow actual generalized adoption; third, new adaptive algorithms, and the integration of aDBS paradigm with new technologies, will improve control of more complex symptoms. Since the next years will be crucial for aDBS implementation, the research should focus on improving precision and making programming procedures more accessible.","M. Guidetti,Tommaso Bocci,Marta De Pedro Del Álamo,Guenther Deuschl,Alfonso Fasano,Raul Martinez-Fernandez,Carmen Gasca-Salas,Clement Hamani,J. K. Krauss,Andrea A. Kühn,Patricia Limousin,S. Little,Andres M Lozano,N. Maiorana,S. Marceglia,M. S. Okun,S. Oliveri,J. L. Ostrem,E. Scelzo,Alfons Schnitzler,P. Starr,Y. Temel,Lars Timmermann,Gerd Tinkhauser,V. Visser-Vandewalle,Jens Volkmann,A. Priori",npj Parkinson's Disease,2025
10.1038/s41531-024-00772-5,39289373,,Sensing data and methodology from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) clinical trial,"Adaptive deep brain stimulation (aDBS) is an emerging advancement in DBS technology; however, local field potential (LFP) signal rate detection sufficient for aDBS algorithms and the methods to set-up aDBS have yet to be defined. Here we summarize sensing data and aDBS programming steps associated with the ongoing Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) pivotal trial (NCT04547712). Sixty-eight patients were enrolled with either subthalamic nucleus or globus pallidus internus DBS leads connected to a Medtronic PerceptTM PC neurostimulator. During the enrollment and screening procedures, a LFP (8–30 Hz, ≥1.2 µVp) control signal was identified by clinicians in 84.8% of patients on medication (65% bilateral signal), and in 92% of patients off medication (78% bilateral signal). The ADAPT-PD trial sensing data indicate a high LFP signal presence in both on and off medication states of these patients, with bilateral signal in the majority, regardless of PD phenotype.","Scott Stanslaski,Rebekah Summers,L. Tonder,Ye Tan,Michelle Case,R. Raike,Nathan Morelli,Todd M. Herrington,M. Beudel,Jill L Ostrem,S. Little,Leonardo Almeida,Adolfo Ramirez-Zamora,A. Fasano,Travis J Hassell,Kyle Mitchell,Elena Moro,M. Gostkowski,N. Sarangmat,Helen Bronte-Stewart",npj Parkinson's Disease,2024
10.1088/1741-2552/ad1dc3,38211344,,Neural signal data collection and analysis of Percept™ PC BrainSense recordings for thalamic stimulation in epilepsy,"Deep brain stimulation (DBS) using Medtronic’s Percept™ PC implantable pulse generator is FDA-approved for treating Parkinson’s disease (PD), essential tremor, dystonia, obsessive compulsive disorder, and epilepsy. Percept™ PC enables simultaneous recording of neural signals from the same lead used for stimulation. Many Percept™ PC sensing features were built with PD patients in mind, but these features are potentially useful to refine therapies for many different disease processes. When starting our ongoing epilepsy research study, we found it difficult to find detailed descriptions about these features and have compiled information from multiple sources to understand it as a tool, particularly for use in patients other than those with PD. Here we provide a tutorial for scientists and physicians interested in using Percept™ PC’s features and provide examples of how neural time series data is often represented and saved. We address characteristics of the recorded signals and discuss Percept™ PC hardware and software capabilities in data pre-processing, signal filtering, and DBS lead performance. We explain the power spectrum of the data and how it is shaped by the filter response of Percept™ PC as well as the aliasing of the stimulation due to digitally sampling the data. We present Percept™ PC’s ability to extract biomarkers that may be used to optimize stimulation therapy. We show how differences in lead type affects noise characteristics of the implanted leads from seven epilepsy patients enrolled in our clinical trial. Percept™ PC has sufficient signal-to-noise ratio, sampling capabilities, and stimulus artifact rejection for neural activity recording. Limitations in sampling rate, potential artifacts during stimulation, and shortening of battery life when monitoring neural activity at home were observed. Despite these limitations, Percept™ PC demonstrates potential as a useful tool for recording neural activity in order to optimize stimulation therapies to personalize treatment.","Z. Sanger,Thomas R Henry,Michael C Park,David P. Darrow,Robert A McGovern,T. Netoff",Journal of Neural Engineering,2024
10.1038/s41531-024-00656-8,38383550,,Coupling between beta band and high frequency oscillations as a clinically useful biomarker for DBS,"Beta hypersynchrony was recently introduced into clinical practice in Parkinson’s disease (PD) to identify the best stimulation contacts and for adaptive deep brain stimulation (aDBS) sensing. However, many other oscillopathies accompany the disease, and beta power sensing may not be optimal for all patients. The aim of this work was to study the potential clinical usefulness of beta power phase-amplitude coupling (PAC) with high frequency oscillations (HFOs). Subthalamic nucleus (STN) local field potentials (LFPs) from externalized DBS electrodes were recorded and analyzed in PD patients ( n  = 19). Beta power and HFOs were evaluated in a resting-state condition; PAC was then studied and compared with the electrode contact positions, structural connectivity, and medication state. Beta-HFO PAC (mainly in the 200–500 Hz range) was observed in all subjects. PAC was detectable more specifically in the motor part of the STN compared to beta power and HFOs. Moreover, the presence of PAC better corresponds to the stimulation setup based on the clinical effect. PAC is also sensitive to the laterality of symptoms and dopaminergic therapy, where the greater PAC cluster reflects the more affected side and medication “off” state. Coupling between beta power and HFOs is known to be a correlate of the PD “off” state. Beta-HFO PAC seems to be more sensitive than beta power itself and could be more helpful in the selection of the best clinical stimulation contact and probably also as a potential future input signal for aDBS.","M. Bočková,M. Lamoš,J. Chrastina,Pavel Daniel,Silvia Kupcová,Ivo Říha,Lucia Šmahovská,M. Baláž,I. Rektor",npj Parkinson's Disease,2024
10.1002/mds.30076,39629629,,Sustained Clinical Benefit of Adaptive Deep Brain Stimulation in Parkinson's Disease Using Gamma Oscillations: A Case Report,,"Stephanie Cernera,C. Oehrn,L. Hammer,Maria M. Shcherbakova,Jiaang Yao,Amelia Hahn,Sarah S Wang,Jill Ostrem,S. Little,P. Starr",Movement Disorders,2024
10.1101/2024.08.26.24312580,39252901,,Adaptive Deep Brain Stimulation in Parkinson’s Disease: A Delphi Consensus Study,"Importance: If history teaches, as cardiac pacing moved from fixed-rate to on-demand delivery in in 80s of the last century, there are high probabilities that closed-loop and adaptive approaches will become, in the next decade, the natural evolution of conventional Deep Brain Stimulation (cDBS). However, while devices for aDBS are already available for clinical use, few data on their clinical application and technological limitations are available so far. In such scenario, gathering the opinion and expertise of leading investigators worldwide would boost and guide practice and research, thus grounding the clinical development of aDBS. Observations: We identified clinical and academically experienced DBS clinicians (n=21) to discuss the challenges related to aDBS. A 5-point Likert scale questionnaire along with a Delphi method was employed. 42 questions were submitted to the panel, half of them being related to technical aspects while the other half to clinical aspects of aDBS. Experts agreed that aDBS will become clinical practice in 10 years. In the present scenario, although the panel agreed that aDBS applications require skilled clinicians and that algorithms need to be further optimized to manage complex PD symptoms, consensus was reached on aDBS safety and its ability to provide a faster and more stable treatment response than cDBS, also for tremor-dominant Parkinsons disease patients and for those with motor fluctuations and dyskinesias. Conclusions and Relevance: Despite the need of further research, the panel concluded that aDBS is safe, promises to be maximally effective in PD patients with motor fluctuation and dyskinesias and therefore will enter into the clinical practice in the next years, with further research focused on algorithms and markers for complex symptoms.","PhD M. Guidetti,MD T. Bocci,M. De,MD Pedro Del Álamo,MD G. Deuschl,MD A. Fasano,MD R. Martinez Fernandez,MD C. Gasca-Salas,MD C. Hamani,J. K. Krauss,MD A. A. Kühn,MD P. Limousin,MD S. Little,MD A.M. Lozano,PhD N.V. Maiorana,PhD S. Marceglia,MD M.S. Okun,PhD S. Oliveri,J. L. Ostrem,MD E. Scelzo,MD A. Schnitzler,MD P.A. Starr,MD Y. Temel,MD L. Timmermann,MD G. Tinkhauser,MD V. Visser-Vandewalle,MD J. Volkmann,MD A. Priori,Kiel Germany",medRxiv,2024
10.1101/2025.02.20.25322374,,,Chronic adaptive versus conventional deep brain stimulation in Parkinson's disease: a blinded randomized pilot trial,,"I. Isaias,S. Marceglia,L. Borellini,Enrico Mailland,F. Cogiamanian,S. Barbieri,A. Ampollini,Elena Pirola,L.G. Remore,L. Caffi,Chiara Palmisano,C. Baiata,Salvatore Bonvegna,L. Romito,R. Eleopra,Vincenzo Levi,A. Bentivoglio,C. Piano,Alessandro Izzo,M. Zibetti,L. Lopiano,Michele Lanotte,Tomasz Mandat,Filippo Tamma,M. Arlotti,C. Conti,L. Rossi,Guglielmo Foffani,Andres M Lozano,E. Moro,J. Volkmann,Marco Locatelli,A. Priori",medRxiv,2025
`;

        function processReferences(csvString) {
            try {
                return parseCSV(csvString);
            } catch (error) {
                console.error("Error parsing CSV string:", error);
                document.getElementById('loadingMessage').textContent = 'Hiba a hivatkozások feldolgozása közben.';
                return [];
            }
        }

        function parseCSV(csvText) {
            const lines = csvText.trim().split('\n');
            if (lines.length < 2) return [];

            const headers = lines[0].split(',').map(header => header.trim().replace(/^"|"$/g, ''));
            const references = [];

            for (let i = 1; i < lines.length; i++) {
                const values = lines[i].split(/,(?=(?:(?:[^"]*"){2})*[^"]*$)/);
                const reference = {};
                headers.forEach((header, index) => {
                    let value = (values[index] || '').trim();
                    if (value.startsWith('"') && value.endsWith('"')) {
                        value = value.substring(1, value.length - 1);
                    }
                    value = value.replace(/""/g, '"');

                    if (header === "Publication Year") {
                        const year = parseInt(value, 10);
                        value = isNaN(year) ? value : year; 
                    }
                    reference[header] = value;
                });
                references.push(reference);
            }
            return references;
        }

        function displayReferences(references) {
            const contentDiv = document.getElementById('referenceContent');
            const loadingMessage = document.getElementById('loadingMessage');

            if (!references || references.length === 0) {
                loadingMessage.textContent = 'Nincsenek megjeleníthető hivatkozások.';
                return;
            }
            
            loadingMessage.style.display = 'none';

            references.sort((a, b) => {
                const yearA = a["Publication Year"] || 0;
                const yearB = b["Publication Year"] || 0;
                if (yearB !== yearA) {
                    return yearB - yearA; 
                }
                const authorsA = (a["Authors"] || "").toLowerCase();
                const authorsB = (b["Authors"] || "").toLowerCase();
                return authorsA.localeCompare(authorsB);
            });

            references.forEach(ref => {
                const itemDiv = document.createElement('div');
                itemDiv.classList.add('reference-item');

                let authors = ref["Authors"] || 'N/A';
                const authorList = authors.split(';').map(a => a.trim());
                if (authorList.length > 3) {
                    authors = `${authorList.slice(0, 1).join('; ')} et al.`;
                } else {
                    authors = authorList.join('; ');
                }

                let doiLink = '';
                if (ref["DOI"] && ref["DOI"] !== "N/A") {
                    doiLink = `<a href="https://doi.org/${ref["DOI"]}" target="_blank" class="doi-link">https://doi.org/${ref["DOI"]}</a>`;
                }

                itemDiv.innerHTML = `
                    <p class="title">${ref["Title"] || 'N/A'}</p>
                    <p class="authors">${authors}</p>
                    <p class="journal">${ref["Journal"] || 'N/A'}</p>
                    <p class="year-doi">
                        <span>${ref["Publication Year"] || 'N/A'}</span>
                        ${ref["DOI"] && ref["DOI"] !== "N/A" ? ` | ${doiLink}` : ''}
                    </p>
                `;
                contentDiv.appendChild(itemDiv);
            });
        }

        document.getElementById('referenceToggle').addEventListener('click', function() {
            const content = document.getElementById('referenceContent');
            content.classList.toggle('hidden');
            const icon = this.querySelector('.toggle-icon');
            if (content.classList.contains('hidden')) {
                icon.classList.remove('fa-chevron-up');
                icon.classList.add('fa-chevron-down');
            } else {
                icon.classList.remove('fa-chevron-down');
                icon.classList.add('fa-chevron-up');
            }
        });

        document.addEventListener('DOMContentLoaded', () => {
            const references = processReferences(csvDataString);
            displayReferences(references);
        });

    </script>
</body>
</html>
